rfhg_157700.1

Basic information about the TSS

---

TSS ID: rfhg_157700.1 TSS ID(Version3): hg_128557.1 Species: human Chr: chr12		Start: 122980672 End: 122980739 Strand: +
Source datasets	FANTOM5|DRA000914|ENCODE|RAMPAGE|PRJNA4843412|PRJNA401781 |PRJNA615891|PRJNA597322|PRJDB5282|PRJNA548673|DRA013844
Protocol	CAGE|RAMPAGE|NETCAGE|SLIC_CAGE|TIF-seq2|STRIPE-seq|C1CAGE |oligo_capping|ReCappable-seq
TSS cluster detected*	14

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2617973,EH38E1652040)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000315580.10:0 ENST00000539576.5:0 ENST00000442210.2:0 ENST00000412505.6:0 ENST00000540708.5:0 ENST00000536502.5:0 ENST00000540382.5:0 NM_001400301.1:0 NM_016638.4:0 NM_001400302.1:0 NM_001278378.2:0 NM_001002251.3:0 NM_001400300.1:0 NM_018694.4:0 NM_001400305.1:0 NM_001400307.1:0 NM_001400304.1:0 NM_001400309.1:0 NM_001400306.1:0 NM_001400303.1:0 NM_001400308.1:0 NM_001400310.1:0 NM_001400313.1:0 NM_001400312.1:0 NM_001400311.1:0 NM_001400314.1:0 NM_001400315.1:0 NM_001400317.1:0 NM_001400319.1:0 NM_001400318.1:0 NM_001400316.1:0 NR_103512.2:0 AB035384:0 AK315759:0 BC001958:0 BC015569:0 GeneID: 51329 HGNC/MGI_ID: HGNC:18076 UniProt_ID: B2RE15 F8WEP2 Q66PJ3 Nearer transcript ids and distances: ENST00000439686.6:9 AF267748:-88 NM_001278380.2:99 ENST00000454885.6:-177 EU624491:-177 ENST00000392433.3:189 AK027285:189 BC094839:-346 ENST00000456762.3:398 KJ902582:400 KJ902583:400 ENST00000357866.4:401 DQ099385:401 ENST00000426960.6:-409 EF036485:416 NM_001400284.1:-439 NM_001278379.2:-439 NM_001400283.1:-439 NM_001400285.1:-439 NM_001400320.1:-439 NM_001400281.1:-439 NM_001400282.1:-439 ENST00000413381.6:-441 ENST00000542099.5:-481 ENST00000392435.7:-481 ENST00000453766.7:-483 ENST00000539770.6:-493 view more...

Gene_name: ARL6IP4 Gene_symbol: ARL6IP4 Gene_synonyms: SFRS20 SR-25 SRp25 SRrp37 Gene_source: HGNC:18076

TATA-Box annotation

---

Distance to TSS:	645
Nearest PromoterID:	NM_016638
Entrez ID:	51329
Nearest Unigene:	Hs.103561
Nearest Refseq:	NM_016638
Nearest Ensembl:	ENSG00000182196
Gene Name:	ARL6IP4
Gene Alias:	SFRS20|SR-25|SRp25|SRrp37
Gene Type:	protein-coding
CpG%:	0.164179
GC%:	0.794118
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ARL6IP4 p2@ARL6IP4 p3@ARL6IP4 p4@ARL6IP4 p5@ARL6IP4 p7@ARL6IP4 p9@ARL6IP4 p10@ARL6IP4
Sample		p1@ARL6IP4	p2@ARL6IP4	p3@ARL6IP4	p4@ARL6IP4	p5@ARL6IP4	p7@ARL6IP4	p9@ARL6IP4	p10@ARL6IP4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	77.34	1.36	0.39	3.51	1.17	2.73	0.39	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	92.05	2.43	0.40	3.44	2.02	1.42	0.00	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	90.09	0.96	0.19	3.47	1.35	3.09	0.00	1.54
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	74.43	1.87	0.62	8.73	1.87	1.46	0.00	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	82.34	2.92	0.90	10.12	1.35	2.47	0.00	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	76.75	2.13	0.39	6.40	1.16	1.94	0.00	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	86.50	1.09	0.44	13.94	2.40	2.61	0.00	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	86.23	1.21	1.21	14.78	1.21	2.66	0.24	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	98.10	1.28	2.14	13.89	4.06	3.21	0.00	2.99
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	99.70	2.32	1.16	18.55	0.58	5.80	0.00	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	80.44	4.45	0.40	16.17	0.81	4.45	0.00	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	82.53	3.66	2.03	18.29	2.44	6.91	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	79.63	1.61	1.29	0.48	0.16	0.64	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	66.61	1.20	1.35	0.45	0.30	0.15	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	77.50	0.88	0.44	0.44	0.22	0.22	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	63.88	0.75	2.01	0.25	0.00	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	62.03	1.31	1.97	0.44	0.44	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	49.77	0.42	0.84	0.42	0.42	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	62.91	1.60	1.07	0.53	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	72.51	1.20	0.90	0.60	0.00	0.30	0.15	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	71.37	1.34	0.94	0.67	0.13	0.40	0.13	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	72.85	1.38	2.07	1.21	0.35	0.35	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	64.89	1.16	1.42	0.39	0.00	0.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	77.41	1.70	0.97	0.24	0.24	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	75.08	1.55	1.03	0.52	0.00	0.00	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	71.85	0.95	2.22	0.63	0.63	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	58.79	0.55	1.10	0.55	0.00	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	82.51	2.12	2.59	0.71	0.24	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	69.29	2.10	1.45	0.81	0.32	0.32	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	82.34	2.90	1.45	1.45	0.36	0.54	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	62.38	1.67	1.05	0.84	0.42	0.00	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	69.36	1.37	1.17	1.95	0.39	0.00	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	51.70	1.27	0.84	1.06	0.00	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	71.25	1.32	1.81	0.33	0.49	0.16	0.16	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	81.34	0.75	0.37	1.12	0.75	0.00	0.37	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	79.33	1.34	0.96	1.34	0.38	0.00	0.38	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	86.04	0.82	2.04	0.61	0.41	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	75.36	1.41	1.81	0.81	0.40	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	63.74	0.81	1.35	0.27	0.00	0.27	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	74.18	2.16	1.92	0.72	0.48	0.00	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	86.81	0.47	1.41	0.47	0.24	0.94	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	69.24	1.46	1.76	1.46	0.44	0.59	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	78.03	1.27	1.90	0.63	0.42	0.42	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	65.04	1.40	2.45	1.22	0.52	0.17	0.00	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	73.88	0.40	1.20	0.80	0.20	0.00	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	61.65	0.47	0.93	0.47	0.00	0.23	0.23	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	73.89	0.72	0.72	0.48	1.20	0.72	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	72.72	0.60	0.89	2.38	0.30	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	64.63	0.96	2.15	0.72	0.48	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	65.92	1.21	1.62	0.20	0.40	0.40	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	58.62	1.02	2.05	1.02	0.41	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	74.72	1.11	1.56	1.33	0.22	0.67	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	223.87	0.00	0.00	13.99	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	65.65	0.71	1.42	0.71	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	73.24	0.66	1.66	0.99	0.00	0.99	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	93.12	1.68	0.00	0.00	2.52	2.52	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	63.38	0.46	0.92	1.84	0.46	0.00	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	90.43	1.62	0.97	0.65	0.97	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	92.82	0.00	1.28	0.32	0.96	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	71.67	1.26	2.51	0.94	0.31	0.94	0.94	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	81.79	0.71	0.71	1.41	0.00	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	84.12	1.68	1.68	0.00	0.56	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	51.75	0.80	2.39	0.00	0.00	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	51.64	1.02	1.70	0.34	0.68	0.00	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	78.31	1.95	0.97	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	71.00	1.06	1.42	0.35	0.71	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	126.36	15.79	15.79	0.00	0.00	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	78.49	2.44	0.00	0.98	0.00	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	82.81	1.49	0.99	0.99	0.50	0.00	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	65.21	1.88	0.94	0.00	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	65.58	2.65	1.32	0.00	0.33	0.33	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	83.21	1.86	0.93	0.00	0.00	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	73.68	1.83	0.92	0.61	0.00	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	65.57	0.32	1.27	0.48	0.48	0.63	0.16	0.32
Adipocyte - breast, donor2	11327-117E4	81.50	0.64	1.28	0.80	0.48	0.80	0.64	0.32
Adipocyte - omental, donor1	11473-119C6	65.52	1.02	0.89	0.38	0.38	0.25	0.00	0.51
Adipocyte - omental, donor2	11474-119C7	76.99	0.75	0.75	1.49	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	75.36	0.33	1.34	0.33	0.00	0.33	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	75.92	1.91	0.00	0.00	0.00	1.28	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	81.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	107.94	0.90	4.97	1.35	0.45	0.00	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	140.58	0.35	3.13	0.52	0.52	0.17	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	116.95	0.59	1.37	0.39	0.78	0.20	0.00	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	73.87	1.03	0.26	1.03	0.00	0.51	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	81.40	0.28	1.67	0.84	0.00	0.00	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	115.80	0.00	1.18	0.59	0.00	0.59	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	135.45	0.40	1.93	0.72	1.21	0.64	0.08	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	101.99	0.32	2.58	0.65	0.32	0.32	0.97	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	80.51	0.00	1.07	0.00	0.00	0.00	1.07	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	110.73	0.56	1.67	0.56	0.00	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	123.52	0.42	2.91	0.00	0.83	0.00	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	82.13	0.00	1.76	0.00	0.25	0.25	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	88.03	0.00	0.65	0.65	0.00	0.98	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	94.08	0.00	3.04	0.91	0.30	0.00	0.30	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	152.71	7.29	4.86	5.97	2.21	1.10	0.66	1.99
Alveolar Epithelial Cells, donor2	11590-120G6	321.29	10.76	4.30	6.45	2.87	2.15	1.08	2.15
Alveolar Epithelial Cells, donor3	11671-122G6	116.21	4.79	1.20	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	133.49	4.14	1.98	1.98	0.90	1.08	0.00	1.44
Amniotic Epithelial Cells, donor2	11613-122A2	160.66	5.02	5.02	0.00	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	127.99	3.29	3.08	1.23	0.62	0.21	0.00	0.41
Anulus Pulposus Cell, donor1	11248-116E6	121.75	2.29	1.83	1.60	0.34	0.69	0.11	0.11
Anulus Pulposus Cell, donor2	11463-119B5	96.74	0.24	5.39	0.24	0.24	0.73	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	80.42	4.04	4.94	1.35	0.00	1.35	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	84.66	3.91	3.91	1.30	0.00	0.00	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	49.23	2.14	6.42	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	90.27	1.49	4.48	1.20	0.30	1.79	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	107.50	3.79	3.79	0.00	1.26	1.26	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	83.83	1.98	0.66	0.66	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	79.27	1.95	2.60	3.25	0.97	0.32	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	104.86	2.91	5.83	0.00	0.97	1.46	0.00	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	77.20	2.97	1.19	1.78	1.19	1.19	0.59	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	82.11	2.64	3.01	1.88	1.13	0.75	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	88.53	4.35	2.18	4.35	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	68.96	0.00	3.76	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	87.31	4.61	2.97	1.48	0.66	0.49	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	76.43	1.36	5.46	0.00	0.00	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	67.71	1.81	2.41	1.21	0.75	0.30	0.00	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	87.33	2.68	2.68	0.54	0.00	0.54	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	91.44	1.51	4.53	2.27	1.13	0.38	0.19	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	68.96	1.60	2.14	1.07	1.07	0.27	0.27	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	70.23	0.98	1.95	2.93	0.00	1.95	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	83.10	1.66	5.14	1.99	0.83	0.50	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	67.24	3.60	3.60	2.40	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	74.34	7.08	7.08	3.54	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	85.08	3.77	2.57	1.89	0.86	0.51	0.00	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	58.73	12.58	4.19	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	84.95	2.91	3.88	0.49	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	89.93	1.14	4.55	1.90	0.38	0.76	0.00	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	69.05	3.63	0.00	6.06	0.00	1.21	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	104.89	2.85	7.98	1.71	0.00	1.14	0.57	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	87.86	3.21	4.06	2.14	0.86	0.64	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	83.36	2.58	3.10	2.84	0.52	0.26	0.00	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	81.64	3.28	3.28	1.88	0.94	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	85.85	1.61	3.22	1.29	1.29	0.96	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	66.35	2.85	2.85	1.43	0.71	0.71	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	71.36	2.92	2.34	0.58	0.58	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	86.71	1.20	2.71	1.81	0.30	0.90	0.00	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	115.24	1.19	1.19	2.38	1.19	1.19	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	105.78	3.56	8.65	2.03	1.02	0.51	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	90.92	2.55	3.31	1.02	0.51	0.51	0.51	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	80.69	1.27	2.54	1.91	0.64	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	81.56	3.88	5.61	2.59	0.86	0.43	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	89.97	2.33	3.39	2.54	0.42	0.64	0.42	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	69.31	2.61	2.90	2.32	0.29	0.29	0.00	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	77.47	2.83	3.78	0.94	0.94	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	89.85	1.70	3.39	1.36	0.34	0.51	0.68	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	69.49	4.63	2.32	0.00	0.00	0.00	0.00	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	73.94	0.00	8.45	0.00	6.34	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	87.48	2.14	2.57	1.07	1.07	0.64	0.21	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	58.36	4.21	0.60	1.80	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	86.75	1.46	4.37	5.10	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	92.64	1.84	4.37	2.07	0.92	0.00	0.23	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	73.96	0.00	0.00	0.00	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	66.10	1.27	3.81	1.78	1.27	0.76	0.51	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	97.03	2.27	4.13	2.48	1.24	0.62	0.00	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	82.93	1.22	2.45	0.92	1.22	1.22	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	90.34	2.39	4.78	2.39	0.00	0.96	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	94.46	1.77	3.10	1.55	1.11	1.33	0.44	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	88.50	1.53	1.53	1.53	0.00	1.53	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	60.37	3.32	5.54	1.11	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	82.88	1.85	4.24	1.32	0.79	0.53	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	63.60	3.27	2.18	1.09	2.18	1.09	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	134.61	10.56	3.44	5.90	1.72	1.35	0.00	1.60
Astrocyte - cerebellum, donor2	11580-120F5	191.53	4.79	3.77	3.94	1.03	0.34	0.00	1.54
Astrocyte - cerebellum, donor3	11661-122F5	119.14	3.15	1.26	2.31	1.05	0.84	0.42	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	110.50	2.09	1.05	1.39	0.35	0.70	0.35	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	120.20	3.40	1.29	4.69	0.81	1.46	0.49	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	119.48	4.33	1.49	1.64	0.89	0.89	0.00	1.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	185.79	2.75	0.57	0.11	0.23	0.69	0.00	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	192.93	1.75	0.38	0.00	0.13	1.25	0.13	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	173.99	2.84	1.02	0.00	0.23	0.57	0.34	0.23
Basophils, donor1	12241-129G9	117.17	0.00	0.00	0.00	0.00	0.26	1.05	0.00
Basophils, donor2	12242-129H1	136.74	0.72	0.36	0.00	0.00	0.00	1.08	0.00
Basophils, donor3	12243-129H2	136.71	0.29	1.18	0.00	0.15	0.15	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	137.55	2.37	3.88	0.43	0.00	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	275.68	8.69	4.57	0.46	0.46	0.91	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	150.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	205.87	0.00	5.65	0.63	2.51	0.63	0.00	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	237.90	3.33	4.37	0.42	0.62	0.62	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	150.38	2.53	2.53	0.23	0.00	0.00	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	110.49	1.08	1.98	0.18	0.00	0.18	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	154.69	1.96	1.03	0.41	0.10	2.16	0.10	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	159.07	3.96	0.93	0.00	0.23	0.93	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	200.50	8.31	2.88	0.32	0.96	1.60	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	268.89	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	148.22	0.00	1.69	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	140.50	0.00	0.37	0.00	0.00	0.56	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	155.21	0.22	0.66	0.22	0.00	0.00	0.66	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	115.77	0.28	0.28	0.28	0.00	0.00	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	95.15	0.00	1.14	0.00	0.38	0.00	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	127.22	0.33	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	95.55	0.14	0.00	0.00	0.00	0.14	0.29	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	89.32	0.00	0.30	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	98.07	0.00	0.24	0.24	0.00	0.47	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	68.13	0.33	0.00	0.00	0.00	0.00	0.33	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	68.45	0.00	0.83	0.00	0.00	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	74.63	0.00	0.74	0.25	0.00	0.00	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	80.87	0.20	0.20	0.00	0.00	0.00	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	77.10	0.18	0.36	0.00	0.00	0.00	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	101.63	0.44	0.44	0.00	0.00	0.00	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	60.40	0.00	0.23	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	82.90	0.00	0.53	0.00	0.00	0.53	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	88.75	0.00	1.11	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	83.89	0.00	0.45	0.00	0.00	0.00	0.30	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	68.44	0.00	0.40	0.00	0.00	0.20	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	87.44	0.00	0.62	0.21	0.00	0.00	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	70.92	0.00	0.23	0.00	0.00	0.00	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	61.98	0.23	0.90	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	46.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	84.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	97.35	0.17	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	99.73	0.00	0.84	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	60.26	0.18	0.18	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	64.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	64.49	0.00	0.88	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	79.34	0.00	0.17	0.00	0.00	0.00	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	85.11	0.00	0.37	0.00	0.00	0.37	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	104.97	0.00	0.00	0.00	0.00	0.00	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	62.65	0.00	0.41	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	56.79	0.00	0.23	0.00	0.00	0.23	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	57.30	0.00	0.00	0.23	0.00	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	175.90	0.44	2.62	0.00	0.22	0.00	1.31	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	182.02	0.92	0.23	0.00	0.23	0.46	1.85	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	157.05	0.43	0.87	0.00	0.00	0.43	0.65	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	149.96	0.31	0.78	0.16	0.00	0.00	0.62	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	133.78	0.35	0.52	0.00	0.00	0.00	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	132.89	0.00	0.89	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	224.04	0.26	1.28	0.26	0.51	0.00	4.59	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	216.93	0.00	2.42	0.00	0.00	1.76	3.95	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	219.39	0.00	2.32	0.00	0.00	0.42	2.32	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	191.04	0.00	4.06	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	206.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	179.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	194.56	0.53	0.53	0.53	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	220.32	1.07	0.00	0.00	0.00	0.00	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	183.91	0.00	0.00	0.00	0.00	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	221.19	0.00	1.57	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	247.84	1.32	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	144.65	0.00	0.00	0.00	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	97.21	0.73	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	98.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	151.52	0.00	0.40	1.21	0.00	2.02	0.81	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	130.23	1.20	1.60	0.80	0.40	1.20	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	67.27	3.01	0.00	0.00	0.00	0.00	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	105.06	6.74	2.81	2.25	0.56	1.12	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	187.50	10.15	2.63	1.50	0.38	3.38	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	210.60	12.63	3.83	1.13	1.35	4.06	0.45	0.23
CD4+ T Cells, donor1	11225-116C1	206.74	0.71	0.71	0.00	0.00	0.00	0.71	0.36
CD4+ T Cells, donor2	11306-117C1	209.43	0.00	1.22	0.00	0.00	0.00	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	186.05	0.30	0.00	0.00	0.00	0.00	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	144.21	1.28	1.02	0.00	0.00	0.00	1.79	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	140.15	0.22	1.12	0.00	0.00	0.00	1.12	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	141.14	0.57	2.01	0.00	0.00	0.00	1.72	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	250.79	0.00	0.95	0.00	0.47	0.00	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	260.56	0.00	2.11	0.00	0.00	0.00	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	237.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	135.84	2.31	1.30	0.00	0.00	0.43	1.01	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	166.58	1.02	0.68	0.00	0.00	0.17	2.88	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	147.83	0.32	1.61	0.16	0.00	0.48	2.10	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	167.66	0.90	0.90	0.00	0.00	0.00	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	193.56	0.35	0.70	0.00	0.00	0.00	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	142.99	0.00	1.32	0.00	0.44	0.00	1.32	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	130.29	1.69	0.42	0.00	0.00	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	171.83	1.66	0.62	0.21	0.00	0.00	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	163.39	1.67	0.33	0.00	0.00	0.67	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	192.53	0.82	1.63	0.00	0.00	0.27	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	253.50	1.07	1.07	0.00	0.00	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	186.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	169.85	2.60	0.93	0.19	0.00	0.19	0.37	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	142.53	1.30	1.30	0.00	0.00	0.43	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	151.73	0.63	0.42	0.00	0.21	0.42	0.63	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	205.28	1.52	1.01	0.00	0.00	0.00	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	235.26	0.87	0.00	0.00	0.00	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	162.12	1.31	0.87	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	262.78	1.48	1.48	0.00	0.00	0.49	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	274.19	1.85	1.85	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	261.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	221.27	0.28	0.83	0.00	0.00	0.00	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	214.23	0.00	0.49	0.00	0.00	0.00	0.49	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	223.30	1.54	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	267.51	0.36	0.36	0.00	0.00	0.00	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	349.02	0.00	2.77	0.00	0.00	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	163.04	0.33	0.00	0.00	0.00	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	159.18	0.38	0.75	0.00	0.00	0.00	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	207.04	0.00	0.00	0.25	0.00	0.25	0.76	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	87.40	0.46	1.15	0.46	2.98	0.23	0.00	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	74.05	0.48	1.68	0.96	3.12	0.24	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	70.59	0.82	0.82	0.55	2.46	0.55	0.27	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	69.95	0.60	2.40	0.90	1.20	0.60	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	79.19	0.72	1.20	0.72	1.68	0.24	0.24	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	84.13	1.82	3.41	0.45	1.82	1.14	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	81.92	1.74	3.04	2.17	2.39	0.87	0.00	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	76.07	0.26	1.32	0.53	2.37	0.26	0.26	1.58
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	73.40	0.47	1.64	1.64	4.46	1.41	0.00	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	90.56	0.00	2.11	0.30	2.11	0.60	0.00	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	68.27	0.87	1.16	0.87	0.58	1.16	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	80.20	0.53	1.60	0.27	2.13	0.53	0.80	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	49.90	0.00	0.88	0.44	4.38	2.19	0.00	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	63.76	0.00	3.19	0.91	1.82	0.91	0.46	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	56.69	0.00	0.75	0.75	0.75	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	88.60	0.72	1.80	0.72	1.08	0.72	0.00	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	87.76	0.00	2.30	1.44	1.73	0.58	0.58	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	82.26	0.71	2.59	1.18	1.41	0.24	0.24	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	74.16	0.63	1.58	1.90	2.54	1.58	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	79.04	2.15	3.38	0.62	4.92	0.31	0.00	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	75.34	0.64	1.28	1.28	2.89	1.60	0.00	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	80.32	0.76	1.53	1.53	1.15	0.38	0.38	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	77.64	0.79	3.15	0.79	3.15	0.39	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	68.08	0.00	2.27	0.00	1.51	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	73.07	0.80	1.61	1.61	0.00	0.80	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	88.13	0.00	3.50	0.00	1.40	0.70	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	85.15	0.00	2.00	1.00	1.00	1.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	62.14	0.00	5.48	0.00	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	132.42	2.47	3.46	4.45	1.48	0.49	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	125.54	7.37	2.42	6.52	0.84	0.95	0.11	1.68
Chondrocyte - de diff, donor1	11261-116G1	130.35	1.04	2.77	3.12	1.73	1.04	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	87.78	1.78	3.20	2.49	1.42	0.36	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	122.20	1.48	3.41	0.91	0.91	0.46	0.11	0.68
Chondrocyte - re diff, donor2	11339-117F7	123.55	2.69	3.58	6.27	1.79	0.90	0.00	2.69
Chondrocyte - re diff, donor3	11411-118E7	124.96	2.83	3.24	1.62	0.00	0.40	0.40	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	105.23	7.46	3.33	2.87	2.07	0.57	0.11	1.49
Ciliary Epithelial Cells, donor2	11323-117D9	101.97	6.20	3.42	3.85	1.07	0.21	0.43	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	117.88	5.49	2.92	2.57	1.95	0.35	0.44	0.80
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	157.17	0.09	2.38	0.37	1.01	0.64	1.38	0.28
Corneal Epithelial Cells, donor1	11526-119I5	210.79	1.54	3.29	0.44	0.00	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	136.51	1.14	2.28	0.00	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	184.31	0.77	3.83	0.00	0.26	0.26	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	101.37	0.17	1.32	0.00	0.99	0.33	0.50	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	109.76	0.63	1.89	0.00	0.32	0.00	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	169.08	3.45	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	100.54	0.22	1.19	0.00	0.22	0.11	0.54	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	139.73	2.39	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	152.12	0.00	0.65	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	129.70	0.48	0.00	0.00	0.00	0.00	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	155.76	2.84	3.00	7.17	1.17	1.17	0.33	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	139.07	4.11	4.11	4.69	0.00	1.17	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	176.47	3.96	3.96	7.07	0.85	0.28	1.41	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	149.41	3.54	1.97	3.15	0.79	1.97	1.18	0.00
Endothelial Cells - Artery, donor1	11264-116G4	142.24	1.16	3.78	2.33	0.87	0.58	0.58	0.58
Endothelial Cells - Artery, donor2	11341-117F9	146.58	3.06	2.59	4.94	0.71	0.94	0.71	0.71
Endothelial Cells - Artery, donor3	11413-118E9	153.40	5.08	2.45	6.66	1.23	0.70	0.35	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	74.48	2.44	1.33	0.00	0.44	0.22	0.89	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	80.02	1.52	0.61	0.91	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	71.60	1.69	1.13	1.41	0.00	0.28	0.28	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	124.50	1.49	3.86	3.27	0.59	0.30	0.59	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	133.29	2.08	2.08	3.64	0.00	0.52	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	119.53	2.69	1.70	1.70	0.57	0.57	0.14	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	164.45	2.00	2.80	5.20	2.00	2.00	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	133.65	4.19	1.57	4.72	0.52	2.10	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	139.90	4.35	1.49	3.73	0.37	0.25	0.75	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	184.02	3.48	2.82	2.39	0.43	0.87	0.87	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	203.59	3.42	2.56	5.01	0.73	2.08	0.73	1.22
Endothelial Cells - Vein, donor1	11267-116G7	174.04	1.14	1.14	9.10	4.55	1.14	1.14	2.28
Endothelial Cells - Vein, donor2	11344-117G3	140.40	4.89	1.40	9.78	0.70	1.40	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	177.26	4.24	2.36	8.16	0.79	0.94	0.47	0.63
Eosinophils, donor1	12244-129H3	76.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	51.16	0.00	1.65	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	49.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	137.80	3.18	2.93	0.73	0.24	0.24	0.00	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	97.77	0.00	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	121.51	0.82	2.87	0.82	1.23	1.23	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	45.55	0.99	3.83	0.33	0.44	0.33	0.44	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	105.30	1.08	2.28	2.06	0.87	0.43	0.11	0.87
Fibroblast - Aortic Adventitial, donor1	11245-116E3	97.87	2.06	3.03	3.03	0.61	0.49	0.00	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	41.76	2.05	4.50	2.59	1.23	0.68	0.00	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	90.91	0.84	3.38	0.95	0.74	0.11	0.11	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	50.06	1.32	1.32	1.32	0.53	0.00	0.00	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	134.21	1.33	2.33	3.99	1.99	0.33	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	123.39	3.18	4.99	2.27	1.81	0.00	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	115.97	9.85	2.27	7.58	0.00	0.76	0.76	1.52
Fibroblast - Cardiac, donor3	11417-118F4	120.02	3.63	3.79	2.05	1.26	0.00	0.00	0.95
Fibroblast - Cardiac, donor4	11452-119A3	92.14	0.61	1.82	3.03	0.30	0.30	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	126.52	1.52	1.52	2.03	0.63	0.51	0.63	0.76
Fibroblast - Cardiac, donor6	11460-119B2	113.70	1.21	1.82	2.58	0.61	0.61	0.15	1.06
Fibroblast - Choroid Plexus, donor1	11492-119E7	113.09	5.49	2.41	2.14	1.07	1.07	0.00	1.74
Fibroblast - Choroid Plexus, donor2	11572-120E6	69.46	3.02	2.59	0.43	0.86	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	131.83	4.39	0.00	5.86	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	200.66	0.92	1.38	2.08	1.38	1.61	0.00	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	110.58	2.04	2.37	0.34	0.17	0.00	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	96.96	0.94	5.63	1.88	0.23	0.23	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	137.26	2.36	2.83	0.94	0.47	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	116.41	0.60	2.78	0.48	0.60	0.24	0.73	0.36
Fibroblast - Dermal, donor4	11450-119A1	124.12	1.92	1.02	2.71	0.23	1.02	0.11	0.45
Fibroblast - Dermal, donor5	11454-119A5	137.47	2.27	0.87	2.09	0.17	1.22	0.17	0.35
Fibroblast - Dermal, donor6	11458-119A9	152.03	2.44	1.14	2.44	0.65	1.46	0.32	0.32
Fibroblast - Gingival, donor1	11237-116D4	111.61	1.46	4.16	0.62	0.21	0.21	0.42	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	107.16	0.79	2.62	1.83	0.79	0.26	0.52	0.26
Fibroblast - Gingival, donor2	11318-117D4	144.17	1.58	3.29	2.24	0.53	0.53	0.40	0.40
Fibroblast - Gingival, donor3	11394-118C8	151.51	0.58	2.13	0.77	0.39	0.19	0.29	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	135.06	3.12	0.00	2.08	0.00	0.00	1.04	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	102.55	0.70	2.11	1.06	0.53	0.70	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	130.17	1.71	3.12	2.18	0.78	1.09	0.31	1.56
Fibroblast - Gingival, donor6 (control)	11922-125H5	97.90	0.81	3.11	2.57	0.54	1.22	0.68	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	36.35	0.00	0.71	1.41	0.71	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	110.71	1.90	2.49	2.19	0.88	1.17	0.15	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	108.40	1.91	4.23	4.09	1.50	1.36	0.82	1.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	115.62	1.65	2.30	2.19	1.54	0.99	0.22	1.21
Fibroblast - Gingival, donor9 (control)	11927-125I1	100.37	0.44	3.23	1.03	1.03	1.47	0.29	1.32
Fibroblast - Lung, donor1	11270-116H1	111.47	0.00	1.36	2.72	0.00	0.00	0.00	2.72
Fibroblast - Lung, donor2	11347-117G6	105.94	2.98	5.97	2.98	0.00	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	130.84	1.69	1.27	1.90	1.06	0.42	0.42	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	225.75	3.33	5.83	5.83	0.83	1.67	0.00	3.33
Fibroblast - Lymphatic, donor2	11586-120G2	166.44	0.00	5.59	1.40	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	147.21	2.24	4.76	2.24	0.28	0.56	0.56	0.28
Fibroblast - Mammary, donor1	11540-120B1	151.83	1.62	2.03	0.81	0.41	0.41	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	203.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	101.26	0.00	5.96	0.00	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	124.92	2.33	2.91	1.75	0.39	0.58	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	173.22	1.37	1.97	3.19	0.30	1.21	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	102.51	0.61	2.45	1.53	1.22	0.92	0.31	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	135.09	2.67	3.43	2.29	1.53	1.14	0.38	1.91
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	126.90	1.62	2.97	1.35	0.81	0.27	0.54	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	115.63	1.04	1.51	0.81	0.70	0.23	0.23	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	124.02	5.31	1.88	5.75	1.44	1.77	0.00	1.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	151.17	1.02	4.67	3.45	1.02	0.41	0.20	1.83
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	207.81	1.34	2.00	1.34	2.67	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	158.54	1.98	2.77	0.40	0.40	0.79	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	45.25	3.97	1.59	5.16	0.60	0.79	0.00	1.19
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	101.42	1.42	1.07	0.71	0.18	0.00	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	106.23	1.77	2.96	1.38	0.39	0.20	0.20	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	58.37	1.50	1.81	5.42	0.30	0.60	0.00	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	120.26	1.94	2.91	1.19	1.08	0.76	0.11	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	43.02	2.02	2.28	2.02	1.27	0.51	0.00	1.01
Fibroblast - skin normal, donor1	11553-120C5	119.12	0.82	2.95	0.82	0.82	0.49	0.00	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	55.74	2.01	3.01	7.22	2.01	1.00	0.40	3.01
Fibroblast - skin normal, donor2	11561-120D4	105.28	2.01	2.81	3.21	2.91	0.70	0.20	1.51
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	50.78	3.02	3.32	4.23	1.51	1.51	0.30	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	102.81	0.83	2.49	0.50	0.91	0.33	0.00	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	102.91	2.05	3.25	0.85	0.68	0.34	0.00	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	41.38	2.96	1.97	2.30	1.31	1.31	0.00	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	102.05	3.73	4.37	2.77	2.13	0.75	0.11	0.75
Fibroblast - skin walker warburg, donor1	11554-120C6	132.92	2.19	1.86	2.70	1.69	0.84	0.17	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	108.36	1.41	1.25	0.78	0.31	0.16	0.31	1.25
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	354.56	0.00	0.00	44.32	0.00	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	135.09	0.00	4.36	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	91.71	2.43	3.81	1.21	0.17	0.35	0.00	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	100.19	2.08	2.86	1.82	0.52	0.26	0.00	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	97.09	2.56	4.09	1.02	0.00	0.26	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	139.33	10.72	3.06	2.30	0.77	1.53	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	95.71	11.49	1.28	0.64	1.91	1.28	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	131.51	10.55	2.00	0.86	1.14	1.71	0.00	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	135.40	2.48	1.65	0.00	0.83	1.65	0.00	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	108.23	4.34	0.68	0.91	0.68	1.60	0.00	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	120.66	8.72	1.19	0.79	0.59	0.79	0.20	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	153.58	1.59	1.85	0.26	0.79	0.53	0.53	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	130.46	1.30	1.30	0.65	0.65	1.96	0.00	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	126.48	14.15	1.33	1.33	0.88	0.44	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	120.69	20.35	0.85	2.54	0.99	1.27	0.28	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	101.96	12.81	1.60	2.96	0.86	0.62	0.25	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	96.44	16.92	2.69	1.88	0.00	0.54	0.00	1.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	98.12	9.79	1.12	7.06	0.50	0.74	0.00	1.36
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	116.83	9.00	0.55	6.92	0.83	0.69	0.28	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	96.16	7.12	0.61	5.29	0.81	0.00	0.20	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	111.12	7.99	1.14	3.65	0.68	0.46	0.23	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	102.64	7.22	0.62	3.99	0.62	0.37	0.12	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	106.45	6.12	0.87	3.72	0.66	0.22	0.66	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	140.06	10.93	0.89	3.55	0.59	0.59	0.00	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	105.23	6.84	2.07	3.18	0.79	1.43	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	130.70	8.94	1.12	3.13	0.45	0.67	0.00	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	124.21	11.09	2.42	2.62	0.81	1.01	0.20	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	116.20	10.35	1.70	4.24	0.85	1.02	0.17	1.87
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	101.53	10.11	1.24	3.99	0.80	0.71	0.09	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	111.34	12.17	1.25	1.35	1.04	0.52	0.10	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	98.54	8.37	3.24	1.20	0.51	0.85	0.17	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	108.77	9.96	1.11	2.21	0.22	0.44	0.22	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	103.25	12.15	1.16	3.41	0.83	0.58	0.17	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	102.70	10.00	2.04	2.45	0.61	0.41	0.41	1.84
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	128.32	11.14	2.48	1.03	0.41	1.24	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	111.03	9.92	1.73	1.96	0.46	0.69	0.00	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	123.74	11.51	2.84	3.50	0.33	0.17	0.00	1.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	122.12	9.48	2.20	2.20	0.88	0.22	0.22	1.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	129.14	9.84	2.21	0.98	1.11	0.37	0.12	0.86
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	110.55	9.89	1.46	2.92	0.81	1.46	0.65	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	151.06	11.23	3.53	0.32	0.32	0.32	0.32	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	110.58	14.69	1.52	5.69	0.85	0.95	0.09	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	119.26	13.60	2.37	6.96	1.58	0.63	0.32	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	102.48	13.38	0.91	3.95	0.61	0.91	0.00	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	97.85	9.51	1.36	7.11	0.73	0.94	0.00	0.94
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	124.93	13.39	1.10	3.07	1.32	0.44	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	94.83	10.10	1.40	1.68	0.28	1.68	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	84.62	3.61	2.50	1.85	0.74	0.65	0.28	0.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	94.93	4.81	1.87	1.87	0.80	0.80	0.00	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	88.44	3.83	2.45	4.74	0.92	0.77	0.00	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	105.83	6.22	2.98	2.72	1.42	1.04	0.13	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	141.50	6.78	1.36	1.36	0.54	0.54	0.54	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	108.03	8.48	2.03	1.11	0.37	0.74	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	110.31	5.48	1.54	0.44	0.88	0.88	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	141.82	11.90	2.98	0.00	1.98	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	102.50	8.71	1.58	0.66	1.06	0.66	0.13	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	99.26	5.85	2.42	0.40	0.61	1.01	0.00	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	82.86	6.61	1.02	0.76	0.00	0.76	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	105.90	16.72	1.99	1.19	0.40	0.20	0.20	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	105.85	9.40	1.08	0.77	0.31	0.15	0.15	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	106.38	12.48	1.23	0.61	0.00	0.41	0.00	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	110.78	15.33	3.13	0.94	0.94	0.63	0.00	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	105.39	16.39	1.70	0.85	1.41	1.98	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	88.55	10.15	0.46	0.92	1.84	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	111.37	9.90	2.47	4.95	4.95	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	123.39	9.67	1.93	0.77	1.93	2.71	0.00	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	118.73	17.65	1.60	3.21	1.60	1.60	0.00	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	92.16	17.39	5.22	1.74	5.22	0.00	0.00	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	101.87	12.04	1.30	0.33	1.63	1.63	0.33	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	107.89	6.59	0.82	0.41	1.65	2.88	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	99.97	13.33	0.00	0.00	6.66	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	102.63	6.71	0.84	1.40	0.56	0.84	0.84	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	107.86	9.15	0.98	0.98	0.98	1.31	0.00	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	102.34	7.55	0.84	0.00	1.68	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	108.78	9.86	1.91	0.64	1.91	0.95	0.32	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	118.54	8.15	1.02	1.70	0.34	0.68	0.00	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	127.38	10.44	4.18	0.00	0.00	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	130.58	7.45	0.57	1.15	1.15	0.00	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	125.20	8.29	1.18	0.00	0.30	0.30	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	105.04	16.94	1.69	3.39	1.69	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	126.75	11.18	0.83	2.07	1.24	1.66	0.00	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	127.26	10.59	1.61	1.61	1.61	2.30	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	163.32	5.27	0.00	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	104.56	9.61	0.00	1.15	1.15	1.15	0.00	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	122.56	16.30	1.96	0.65	0.98	0.98	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	146.48	14.05	0.67	0.67	0.00	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	142.16	7.71	2.70	0.77	2.31	0.77	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	133.17	10.27	1.03	2.74	1.03	1.37	0.00	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	106.85	9.94	2.48	2.48	0.00	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	177.89	7.08	1.42	0.00	0.47	0.47	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	147.86	6.64	2.41	1.81	1.21	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	135.31	6.61	1.53	0.00	0.51	0.51	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	147.57	7.18	1.60	1.60	0.00	0.80	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	156.39	12.33	1.48	0.49	0.00	0.99	0.00	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	132.21	9.44	2.36	3.54	1.18	0.00	1.18	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	133.61	5.25	0.58	1.17	0.58	1.75	0.00	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	136.49	10.53	0.88	0.44	0.88	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	101.72	4.24	2.54	0.00	1.70	1.70	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	95.51	7.76	0.60	1.19	0.00	1.79	0.00	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	127.62	11.16	2.43	2.43	0.97	0.49	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	94.73	4.57	1.14	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	100.63	2.49	3.33	0.83	0.42	0.42	0.00	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	137.18	1.12	4.50	2.25	1.12	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	95.78	0.63	3.17	0.32	0.00	0.32	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	77.70	0.84	3.76	0.42	0.42	0.84	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	106.64	0.70	3.48	0.93	0.81	0.35	0.12	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	107.36	2.53	4.56	1.01	0.34	0.51	0.34	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	103.29	2.05	3.41	1.37	0.91	1.14	0.00	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	109.86	1.97	2.08	0.66	0.55	0.55	0.22	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	121.86	3.22	3.87	0.43	0.86	0.21	0.00	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	108.29	2.15	3.44	1.94	0.43	0.86	0.43	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	110.46	2.49	4.11	1.00	0.62	0.50	0.62	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	104.82	1.89	3.77	0.69	0.17	0.51	0.51	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	107.32	3.84	0.96	0.64	0.32	1.28	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	147.18	2.80	0.56	1.12	0.56	0.56	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	158.84	4.33	3.03	4.76	1.73	1.30	0.00	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	95.18	0.00	0.00	13.22	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	156.26	6.35	3.53	2.12	1.76	1.06	0.71	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	133.68	5.09	7.27	0.73	0.73	2.18	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	121.69	4.55	1.75	5.59	0.35	1.57	0.17	1.05
Hepatocyte, donor1	11523-119I2	136.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	160.52	0.00	4.31	0.00	0.00	2.15	0.00	0.00
Hepatocyte, donor3	11684-122I1	150.32	0.00	0.00	0.00	0.00	1.23	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	168.39	3.26	0.00	1.31	1.96	5.22	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	84.59	5.59	3.50	0.00	0.35	1.75	0.17	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	92.89	8.51	2.88	7.13	2.20	1.37	0.27	1.65
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	117.80	0.00	0.00	3.18	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	80.10	0.00	20.03	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	105.21	0.00	4.15	1.38	0.00	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	82.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	0.00	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	97.39	0.00	0.00	0.00	0.00	5.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	95.99	4.57	0.00	13.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	118.58	0.00	3.25	3.25	1.62	3.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	93.37	1.67	6.67	5.00	0.00	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	68.98	0.00	0.00	3.63	0.00	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	100.58	0.00	1.32	5.29	1.32	6.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	116.41	1.11	0.00	1.11	1.11	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	94.29	0.00	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	93.85	0.00	1.26	2.52	0.63	1.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	125.28	3.09	3.09	1.55	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	104.66	0.65	3.88	1.94	0.00	1.29	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	103.04	1.61	4.83	4.83	0.00	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	0.00	0.00	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	122.23	1.63	1.63	1.63	0.00	2.44	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	78.92	1.26	2.94	1.68	0.00	0.84	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	100.61	43.12	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	103.68	0.00	0.80	1.61	0.00	2.41	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	96.94	1.85	3.69	5.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	135.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	102.90	0.00	1.42	1.89	0.00	4.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	104.30	0.00	0.00	0.91	0.91	1.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	103.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	104.38	0.00	2.15	0.00	0.00	2.15	1.08	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	115.61	1.27	2.54	3.81	0.00	2.54	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	230.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	108.41	1.28	1.91	1.91	0.00	5.10	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	102.07	1.82	3.65	0.00	0.00	1.82	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	79.26	0.00	2.14	2.14	0.00	0.71	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	132.73	0.00	3.32	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	104.64	0.62	3.40	0.93	0.00	1.85	0.62	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	110.63	0.00	3.51	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	100.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	81.36	0.70	1.39	2.09	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	172.62	0.00	2.21	0.00	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	119.95	0.00	3.24	0.00	0.00	3.24	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	125.56	0.00	3.49	0.00	0.00	6.10	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	182.23	0.00	6.75	0.00	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	108.02	0.00	3.48	0.00	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	122.68	0.00	1.07	0.00	0.00	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	105.29	1.39	6.93	2.77	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	96.89	2.85	8.55	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	146.35	0.92	1.84	2.76	0.00	2.76	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	151.27	0.00	3.03	0.00	0.00	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	105.55	0.00	6.21	0.00	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	167.06	0.00	1.06	0.00	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	72.87	1.47	2.77	0.49	0.49	0.16	0.08	0.24
Keratinocyte - epidermal, donor2	11349-117G8	113.61	2.34	1.17	0.59	0.00	0.59	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	142.84	1.14	1.51	0.66	0.19	0.09	0.00	0.28
Keratinocyte - oral, donor1	11251-116E9	186.96	2.61	2.50	0.79	0.00	0.00	0.11	0.00
Keratocytes, donor1	11527-119I6	287.44	2.75	3.09	0.34	2.06	1.72	0.00	0.69
Keratocytes, donor2	11607-120I5	158.19	2.34	2.34	8.20	1.17	1.17	2.34	0.00
Keratocytes, donor3	11688-122I5	90.70	0.20	0.99	0.00	0.00	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	404.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	77.67	10.79	1.08	6.47	2.16	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	110.72	4.73	3.23	2.42	1.15	0.12	0.00	0.69
Lens Epithelial Cells, donor3	11690-122I7	57.72	5.35	2.62	2.22	1.01	0.30	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	123.32	3.32	0.95	3.08	0.83	0.83	0.24	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	101.58	2.79	2.23	0.84	0.00	0.56	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	113.34	2.36	1.73	2.20	0.63	0.31	0.47	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	108.62	2.69	1.08	2.69	0.54	0.54	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	117.24	2.21	0.95	1.58	0.00	0.00	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	121.51	3.77	1.51	2.16	0.54	0.43	0.43	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	93.16	2.87	2.46	3.69	0.00	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	121.10	2.53	1.26	1.77	1.01	0.51	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	119.64	2.96	1.13	2.82	0.14	0.42	0.42	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	85.44	2.77	1.98	3.16	0.40	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	111.29	2.13	0.97	1.55	0.19	0.39	0.19	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	131.09	4.81	1.30	1.67	0.56	0.93	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	121.95	1.74	1.39	3.14	1.05	0.70	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	103.28	3.10	0.72	1.91	0.48	0.00	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	114.41	4.53	1.79	3.02	0.82	1.24	0.41	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	107.48	2.46	1.54	1.85	0.31	1.23	1.23	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	117.84	2.49	1.56	2.81	0.94	0.94	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	128.28	4.76	1.10	2.38	0.37	0.91	0.91	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	126.05	1.65	0.33	3.62	0.66	0.66	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	111.29	2.64	1.76	2.05	0.00	0.59	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	126.95	4.73	3.24	1.49	0.25	0.25	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	109.60	2.91	0.97	1.45	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	112.30	2.15	1.08	3.23	0.27	0.81	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	124.13	2.88	1.36	2.12	0.30	0.76	0.30	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	111.98	0.52	2.59	2.59	0.52	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	108.05	1.88	0.63	1.05	0.21	1.05	0.21	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	120.30	3.31	1.35	2.56	0.75	0.90	0.15	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	106.62	4.82	0.69	4.82	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	96.90	2.07	0.56	1.51	0.38	0.56	0.19	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	122.99	2.76	1.70	1.70	0.32	0.64	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	106.61	1.45	2.42	1.45	0.00	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	96.26	1.98	0.99	2.32	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	123.77	3.96	1.73	1.73	0.37	1.12	0.37	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	102.18	3.70	1.85	0.74	0.00	0.74	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	93.15	1.24	0.74	2.96	0.74	0.00	0.49	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	120.31	2.89	0.96	2.47	0.27	0.82	0.14	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	102.92	2.89	0.64	2.25	0.32	0.96	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	97.99	1.22	0.61	2.43	0.00	0.91	0.30	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	117.99	2.66	1.54	2.80	0.42	0.84	0.42	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	101.69	2.13	2.84	3.56	1.78	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	87.74	1.45	0.97	3.88	0.00	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	144.72	3.27	1.40	2.49	0.16	0.78	0.31	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	104.21	1.79	1.79	2.51	0.72	0.72	0.72	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	100.62	1.31	0.98	1.63	0.65	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	129.72	2.59	0.71	2.12	0.00	1.18	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	106.06	1.98	2.23	3.47	0.25	0.99	0.12	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	102.96	1.28	0.26	3.59	0.77	0.26	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	147.09	1.79	2.39	4.18	0.00	1.19	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	97.44	2.27	9.06	0.00	0.00	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	115.84	0.77	1.53	0.77	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	98.72	2.23	4.45	0.74	0.00	0.74	0.74	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	85.05	1.27	1.69	0.00	0.00	1.27	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	96.36	2.81	4.22	0.00	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	87.79	0.93	1.87	0.00	0.93	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	84.50	1.03	1.55	0.00	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	107.05	1.19	3.57	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	90.70	1.36	3.62	0.68	1.36	0.45	0.68	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	95.97	2.62	2.91	0.29	0.58	2.04	1.16	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	111.19	0.90	2.25	0.45	1.35	0.00	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	87.93	1.76	1.63	0.54	0.68	0.54	0.14	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	81.14	2.05	1.54	0.51	0.51	3.59	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	93.15	1.41	2.82	0.35	0.00	0.71	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	90.62	0.00	1.33	0.67	0.00	2.00	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	77.94	0.51	4.08	0.51	1.02	1.53	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	107.79	1.87	2.93	0.00	0.27	0.53	0.27	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	111.10	0.76	2.65	0.38	0.94	0.94	0.76	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	73.63	1.23	3.07	0.61	1.23	0.61	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	113.34	1.63	6.52	0.00	0.00	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	105.16	1.87	2.50	0.00	0.62	0.21	0.21	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	102.30	0.84	2.80	0.56	0.84	0.84	0.84	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	89.64	1.03	2.06	1.03	1.03	0.00	0.00	4.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	103.64	2.32	3.48	0.29	0.58	1.16	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	101.94	0.90	4.19	0.30	0.00	0.60	0.30	1.79
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	116.74	1.11	4.43	0.00	1.66	0.55	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	86.60	1.06	1.77	0.71	2.83	0.35	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	92.93	0.74	3.32	0.00	0.00	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	115.13	1.15	4.61	1.15	0.00	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	102.85	0.38	3.84	0.00	1.15	0.77	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	53.22	0.00	1.70	1.13	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	119.79	0.82	4.10	0.00	0.00	1.64	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	86.31	0.90	1.81	0.45	0.45	0.45	0.45	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	87.61	0.00	5.75	0.00	1.44	0.00	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	108.30	2.24	5.23	0.75	0.00	0.75	0.75	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	87.70	0.74	3.72	0.00	0.37	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	90.46	1.29	0.86	0.00	1.29	1.72	0.43	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	94.19	1.71	7.71	0.00	2.57	0.86	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	108.28	1.33	2.67	0.33	1.33	0.67	1.33	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	83.86	1.21	3.62	0.60	0.00	1.81	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	98.12	0.71	1.42	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	98.30	1.03	3.78	0.00	1.37	0.69	0.34	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	68.17	1.61	4.29	0.00	0.00	0.54	0.54	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	94.27	1.35	0.67	1.35	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	102.60	0.37	2.96	1.11	0.37	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	110.48	1.16	2.33	0.00	0.00	1.16	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	79.33	2.12	1.06	0.00	1.06	1.06	1.06	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	100.84	2.00	2.80	0.00	0.40	0.80	0.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	66.15	2.18	2.18	0.73	0.00	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	98.11	0.00	3.07	0.00	0.77	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	86.32	1.97	4.93	0.49	0.00	0.49	0.00	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	74.33	0.00	3.76	0.00	0.00	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	111.12	1.51	3.02	1.01	1.01	0.50	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	87.42	0.90	3.15	0.45	0.90	1.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	58.52	0.00	1.72	0.00	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	91.74	0.89	0.89	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	89.94	1.56	1.96	0.00	0.00	1.17	0.00	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	67.29	1.98	1.98	0.00	0.66	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	107.42	2.08	2.59	1.56	0.52	1.56	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	77.01	0.88	2.63	0.00	0.44	0.88	1.31	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	84.42	0.56	3.35	0.00	1.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	104.67	0.00	3.53	0.44	0.44	1.32	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	99.13	2.70	1.54	0.00	1.16	0.77	0.39	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	78.48	1.52	3.54	1.01	0.51	0.51	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	99.49	0.48	1.44	1.44	0.48	0.00	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	101.37	0.80	2.78	0.80	1.59	0.80	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	83.24	0.61	1.22	0.00	0.61	0.00	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	80.24	0.00	4.15	0.69	2.08	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	83.98	1.14	2.66	1.52	0.76	0.00	0.00	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	74.36	0.52	1.03	1.03	2.07	1.55	0.00	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	58.65	1.21	2.42	0.00	0.60	0.00	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	96.65	0.95	1.27	0.63	1.58	0.00	0.00	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	76.23	0.53	4.26	1.07	2.13	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	78.73	2.87	1.15	0.00	1.15	0.57	0.00	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	99.25	0.51	1.54	0.00	1.03	1.03	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	85.59	1.41	2.83	0.71	2.12	0.71	0.00	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	72.64	1.70	4.54	0.57	4.54	0.57	0.00	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	86.53	0.83	4.58	1.25	1.66	1.25	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	69.69	2.35	1.57	0.78	0.78	0.78	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	73.91	1.25	2.92	0.42	1.25	0.00	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	81.31	2.79	3.25	1.39	0.93	1.39	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	76.27	0.67	4.68	1.34	1.34	1.34	0.67	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	82.87	2.67	2.67	1.60	1.07	1.07	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	82.44	2.83	3.23	0.81	1.62	1.21	0.00	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	82.60	0.92	0.92	1.84	0.92	0.00	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	73.80	3.56	5.33	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	101.44	2.28	3.99	0.00	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	84.36	1.53	0.77	1.53	1.53	2.30	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	79.34	1.64	1.64	0.00	0.00	1.09	0.00	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	100.67	0.45	2.67	2.23	0.89	0.45	0.45	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	93.06	1.82	2.08	1.30	2.60	0.52	0.26	3.12
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	102.78	1.33	3.32	1.99	3.32	0.66	0.00	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	97.69	0.00	2.08	0.00	2.08	0.00	2.08	4.16
Macrophage - monocyte derived, donor1	11232-116C8	100.97	0.23	1.60	0.00	0.00	0.00	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	68.45	0.18	0.55	0.00	0.55	0.18	0.00	0.92
Macrophage - monocyte derived, donor3	11389-118C3	103.03	0.26	1.18	0.13	0.79	0.00	0.39	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	109.92	4.78	4.25	2.12	0.00	0.00	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	90.16	2.69	3.80	1.27	0.32	0.32	0.16	0.32
Mallassez-derived cells, donor3	11930-125I4	108.27	2.36	4.86	2.22	0.56	0.56	0.14	0.56
Mammary Epithelial Cell, donor1	11273-116H4	163.02	1.99	2.59	1.30	0.70	0.90	0.10	0.30
Mammary Epithelial Cell, donor2	11350-117G9	130.01	2.32	4.05	2.32	0.00	0.58	0.00	0.58
Mammary Epithelial Cell, donor3	11422-118F9	119.48	0.75	2.00	0.50	0.25	0.50	0.25	0.50
Mast cell - stimulated, donor1	11487-119E2	183.72	2.03	0.68	0.00	2.03	0.00	1.36	1.36
Mast cell, donor1	11563-120D6	158.43	1.30	1.73	0.11	0.32	0.32	1.19	0.11
Mast cell, donor2	11565-120D8	202.38	1.49	1.19	0.00	0.59	0.00	1.78	0.00
Mast cell, donor3	11566-120D9	205.99	1.80	0.90	0.00	0.00	0.00	1.35	0.45
Mast cell, donor4	11567-120E1	188.81	0.71	0.35	0.00	0.00	0.00	1.24	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	120.76	0.89	0.55	0.33	0.55	0.22	0.11	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	75.88	2.92	0.00	1.75	1.75	1.17	0.58	1.17
Mast cell, expanded, donor5	11939-126A4	147.88	1.03	1.49	0.00	0.34	0.00	0.80	0.11
Mast cell, expanded, donor8	11941-126A6	132.22	2.34	1.67	0.17	0.50	0.50	3.18	0.00
Melanocyte - dark, donor1	11502-119F8	143.87	2.49	0.50	0.80	0.30	0.10	0.50	0.30
Melanocyte - dark, donor2	11582-120F7	116.63	2.08	1.38	2.08	0.69	0.69	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	133.80	1.30	3.04	2.10	2.10	0.43	0.14	0.80
Melanocyte - light, donor1	11274-116H5	102.02	0.71	3.53	1.18	1.41	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	102.37	0.00	4.78	0.00	0.68	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	91.93	2.60	3.47	0.00	0.87	0.87	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	112.35	1.87	3.96	2.19	1.35	1.25	0.21	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	81.22	1.08	2.96	1.88	1.08	0.54	0.27	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	101.25	1.61	2.14	0.00	0.27	0.27	0.27	0.00
Meningeal Cells, donor1	11493-119E8	167.36	5.09	2.73	6.08	1.24	0.74	0.00	1.24
Meningeal Cells, donor2	11573-120E7	147.45	4.40	1.76	3.52	0.88	0.88	0.44	0.44
Meningeal Cells, donor3	11654-122E7	107.66	4.48	1.47	4.97	0.82	1.14	0.16	1.22
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	158.55	4.28	3.99	4.28	0.86	0.57	0.29	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	57.46	2.42	1.31	1.01	1.01	0.30	0.00	1.01
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	318.03	3.94	5.26	2.63	2.63	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	223.70	2.62	5.23	6.54	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	121.99	1.44	5.02	5.02	0.72	0.00	0.00	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	54.21	2.33	5.51	0.42	1.27	0.21	0.42	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	59.81	1.01	6.03	1.51	1.51	1.51	1.01	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	156.46	5.27	3.52	9.01	3.08	0.88	0.00	2.20
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	179.72	2.92	0.73	6.58	0.73	2.19	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	152.02	4.71	4.50	5.73	1.84	1.23	1.02	2.05
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	99.73	3.19	4.29	1.25	0.55	0.97	0.14	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	136.79	1.49	3.35	1.49	0.37	3.72	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	105.79	4.87	1.32	1.32	0.39	1.05	0.26	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	102.67	5.64	5.04	0.30	0.30	35.31	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	170.49	2.34	2.34	4.67	0.00	28.03	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	163.94	8.33	1.92	1.92	1.28	1.92	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	136.46	4.25	3.19	7.44	1.42	1.42	0.00	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	124.46	3.75	0.63	0.63	0.31	0.63	0.00	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	142.96	5.81	0.73	2.18	1.45	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	73.72	1.06	5.57	1.86	0.27	0.00	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	62.06	0.00	4.50	0.00	0.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	70.82	0.72	2.60	0.94	0.29	0.51	0.22	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	186.34	0.00	4.05	0.00	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	115.75	0.49	1.23	0.25	1.97	0.25	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	83.63	0.00	1.18	0.59	1.18	0.00	0.00	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	131.37	3.46	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	80.28	0.00	1.24	0.62	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	63.89	0.62	1.45	0.00	1.45	0.21	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	118.12	4.63	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	101.11	0.25	1.50	0.00	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	72.15	0.00	0.00	0.00	0.93	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	175.20	0.00	38.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	92.06	0.20	0.61	0.00	1.22	0.20	0.41	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	67.31	0.40	0.79	0.00	1.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	384.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	73.45	0.88	1.77	0.00	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	78.27	0.00	0.76	0.00	1.90	0.00	0.00	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	109.22	0.00	1.32	0.00	1.32	0.00	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	80.65	0.00	0.85	0.21	1.70	0.21	0.42	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	53.41	0.00	0.92	0.00	3.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	61.70	0.30	0.30	0.30	0.30	0.30	0.30	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	87.19	0.00	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	203.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	65.23	0.50	0.00	0.25	0.50	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	56.09	0.24	1.19	0.00	1.19	0.00	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	97.86	0.00	1.66	0.00	0.55	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	65.16	0.00	1.61	0.00	1.61	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	57.00	0.00	0.84	0.00	1.68	0.21	0.63	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	53.40	0.00	0.82	0.00	0.00	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	66.29	0.00	0.21	0.00	1.07	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	56.91	0.00	0.67	0.00	0.67	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	175.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	51.25	0.00	0.22	0.22	0.66	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	68.95	0.00	0.51	0.00	1.01	0.51	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	91.13	0.00	0.00	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	61.97	0.00	0.27	0.00	0.54	0.00	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	48.82	0.00	0.59	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	66.51	0.00	2.18	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	60.55	0.00	0.48	0.00	0.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	49.23	0.00	0.40	0.00	1.20	0.00	0.00	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	80.90	0.00	1.37	0.00	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	62.57	0.00	0.50	0.50	1.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	85.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	49.92	0.00	0.00	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	65.12	0.00	2.21	0.00	1.10	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	91.58	0.64	1.28	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	58.51	0.50	1.49	0.00	0.74	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	91.86	0.00	0.00	0.00	1.39	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	103.86	0.00	2.21	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	64.27	2.05	0.68	0.34	0.68	0.00	0.34	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	70.89	0.00	0.44	0.00	0.00	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	79.54	1.42	0.36	0.71	0.36	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	64.53	1.12	0.28	0.00	1.68	0.56	0.28	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	56.11	0.00	0.00	0.42	0.83	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	77.51	0.58	0.58	0.00	0.00	0.58	0.00	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	53.39	0.60	0.30	0.60	1.81	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	53.43	0.00	0.00	0.00	1.67	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	86.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	44.33	2.77	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	66.02	0.00	0.57	0.57	0.57	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	61.91	1.52	0.41	0.00	0.14	0.14	0.14	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	50.53	1.30	0.78	1.04	0.00	0.52	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	59.63	0.43	0.86	0.00	0.86	0.43	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	73.68	0.64	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	58.18	0.53	1.07	0.00	0.27	0.27	0.27	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	72.14	0.30	0.90	0.30	0.30	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	57.77	1.13	0.99	0.28	0.00	0.57	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	49.37	0.96	0.96	0.32	1.27	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	60.81	0.00	0.66	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	66.74	0.38	0.38	0.00	0.76	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	52.28	1.70	0.28	0.00	0.28	0.28	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	56.04	0.00	0.98	0.00	0.00	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	84.07	0.00	1.30	0.65	1.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	64.10	0.88	0.59	0.00	0.59	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	66.89	0.29	2.02	0.00	0.58	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	84.90	0.82	2.47	0.00	0.41	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	70.57	0.00	0.89	0.30	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	90.41	0.00	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	99.81	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	123.54	0.00	0.99	0.00	0.00	0.00	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	120.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	75.32	0.00	0.20	0.00	0.00	0.00	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	116.42	0.00	0.00	0.00	0.93	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	132.19	0.38	0.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	104.94	0.00	0.53	0.00	0.27	0.00	0.80	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	77.70	0.90	0.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	110.51	0.74	0.00	0.00	0.74	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	98.57	0.00	0.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	79.34	0.00	1.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	71.08	0.53	0.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	85.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	125.23	2.02	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	109.63	0.00	0.00	0.00	2.11	0.00	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	65.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	28.61	0.64	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	21.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	95.16	1.51	1.51	0.00	0.00	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	91.36	0.00	0.00	0.00	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	130.50	0.00	3.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	71.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	138.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	101.90	4.09	2.37	4.31	2.37	0.43	0.00	1.51
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	152.08	2.09	5.75	1.05	0.52	0.00	0.52	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	57.40	1.33	0.67	2.00	0.00	0.00	0.00	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	80.55	0.42	2.09	0.83	0.83	0.42	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	81.19	1.14	2.85	2.66	0.95	0.76	0.38	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	481.95	6.38	17.55	1.60	4.79	6.38	0.00	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	46.24	0.68	0.68	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	91.88	0.00	3.68	0.00	1.84	0.00	9.19	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	59.01	0.42	1.67	0.84	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	75.54	0.70	1.63	0.70	1.39	0.46	0.00	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	56.75	0.27	2.97	0.00	0.27	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	114.37	0.84	2.73	1.47	0.84	0.00	0.00	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	111.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	59.56	0.00	1.99	0.50	0.00	0.50	2.48	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	55.76	0.54	1.89	0.81	0.54	0.27	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	46.47	0.00	1.59	0.23	0.23	0.00	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	51.60	0.33	1.14	0.16	0.49	0.00	0.00	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	89.12	0.18	3.10	0.55	0.36	0.36	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	53.57	0.00	2.12	1.06	0.53	0.00	0.53	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	55.83	0.00	3.60	0.00	1.20	0.60	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	45.62	0.98	2.95	1.64	0.00	0.00	0.33	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	47.16	0.16	1.30	0.00	0.00	0.00	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	119.41	0.71	1.76	0.53	0.35	0.18	0.00	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	72.43	0.00	1.41	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	69.88	0.00	1.84	0.00	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	72.95	0.32	0.96	0.00	0.32	0.00	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	52.77	0.00	2.41	0.00	0.34	0.00	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	103.67	2.53	5.06	5.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	120.08	0.45	2.01	0.22	1.34	0.45	0.00	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	60.97	0.00	0.00	0.00	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	56.01	0.47	0.47	0.24	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	74.26	1.72	1.29	1.72	0.86	0.00	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	0.00	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	59.31	0.67	2.00	0.00	0.67	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	101.90	0.00	0.45	0.00	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	44.44	0.00	1.19	0.40	1.19	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	67.79	0.93	0.93	0.93	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	85.51	1.14	1.51	1.14	1.14	0.38	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	59.31	0.33	0.65	0.33	0.98	0.00	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	68.42	0.00	0.00	0.00	1.31	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	132.52	3.62	4.52	0.90	1.81	1.36	0.00	2.26
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	55.56	0.00	1.76	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	63.16	0.00	0.66	0.00	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	75.40	0.00	1.49	0.00	0.50	0.00	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	63.17	0.38	0.77	0.00	0.38	0.00	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	78.94	0.30	1.51	0.30	0.91	0.00	0.00	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	85.32	1.55	1.33	1.11	1.77	0.00	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	50.82	0.00	0.00	0.68	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	81.75	0.00	0.00	0.00	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	71.33	0.61	1.22	0.00	0.61	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	63.26	0.00	0.94	0.00	0.63	0.31	0.00	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	66.89	0.61	1.82	0.00	0.91	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	47.47	0.00	1.58	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	52.15	0.00	2.27	1.13	2.27	0.00	3.40	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	80.93	0.00	10.12	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	64.35	2.11	3.60	1.99	1.61	0.62	0.62	1.12
Myoblast, donor2	11322-117D8	106.44	1.92	3.45	1.53	2.11	0.38	0.77	0.00
Myoblast, donor3	11398-118D3	96.19	1.85	4.37	3.20	0.84	0.84	0.67	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	202.55	1.02	0.73	0.00	0.00	2.33	0.29	0.44
Natural Killer Cells, donor1	11230-116C6	143.00	0.62	0.31	0.00	0.00	0.62	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	149.27	0.30	0.00	0.00	0.00	0.30	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	164.73	0.55	0.18	0.18	0.18	0.00	0.18	0.00
Neural stem cells, donor1	11275-116H6	63.51	5.08	2.54	1.09	2.90	1.81	0.00	2.54
Neural stem cells, donor2	11352-117H2	80.88	0.00	1.93	3.85	0.00	0.00	0.00	5.78
Neurons, donor1	11494-119E9	83.07	1.14	1.14	1.14	2.28	1.14	0.00	3.41
Neurons, donor2	11574-120E8	76.84	1.76	1.10	3.30	0.44	0.44	0.00	1.98
Neurons, donor3	11655-122E8	109.35	1.64	1.64	1.64	6.58	0.82	0.82	1.64
Neutrophils, donor1	11233-116C9	22.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	26.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	20.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	124.08	1.78	2.49	1.19	0.36	0.47	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	112.33	1.95	2.28	0.33	0.65	0.33	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	118.33	2.61	2.21	0.60	0.40	0.00	0.20	0.40
Olfactory epithelial cells, donor1	11933-125I7	115.63	2.06	2.75	0.83	0.69	0.00	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	141.27	1.88	1.88	0.72	0.87	0.14	0.14	0.43
Olfactory epithelial cells, donor3	11935-125I9	121.79	1.82	2.84	0.23	0.45	0.11	0.00	0.68
Olfactory epithelial cells, donor4	11936-126A1	107.53	0.49	2.14	0.39	0.49	0.39	0.19	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	145.04	5.42	1.81	1.20	0.60	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	113.15	1.70	6.38	0.85	0.64	0.85	0.21	0.85
Osteoblast - differentiated, donor2	11353-117H3	105.17	2.29	6.86	0.00	2.29	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	155.18	1.24	0.62	2.48	0.00	1.24	0.62	0.62
Osteoblast, donor1	11277-116H8	278.89	9.77	6.84	8.21	4.89	1.95	0.39	5.67
Osteoblast, donor2	11354-117H4	104.65	3.51	2.11	4.92	3.51	2.81	0.70	0.70
Osteoblast, donor3	11426-118G4	175.06	6.93	3.20	5.33	1.96	1.07	0.00	1.96
Pancreatic stromal cells, donor1	11249-116E7	98.13	1.60	3.20	1.60	0.59	0.25	0.34	0.17
Pericytes, donor1	11491-119E6	124.06	4.56	3.78	0.22	1.22	0.56	0.22	0.56
Pericytes, donor2	11571-120E5	154.61	4.98	4.53	1.36	0.91	0.45	0.23	1.81
Pericytes, donor3	11652-122E5	154.42	9.16	4.27	8.54	2.85	1.42	0.81	2.03
Perineurial Cells, donor1	11499-119F5	138.45	8.93	3.05	5.43	0.79	0.57	0.11	0.79
Perineurial Cells, donor2	11579-120F4	121.36	3.22	2.67	3.31	1.20	0.55	0.00	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	160.33	0.00	0.32	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	134.18	0.24	0.73	0.00	0.00	0.00	0.49	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	148.57	0.13	0.91	0.13	0.00	0.13	0.52	0.00
Placental Epithelial Cells, donor1	11278-116H9	134.41	6.46	3.59	1.91	0.96	0.24	0.48	0.72
Placental Epithelial Cells, donor2	11355-117H5	150.81	5.54	1.11	1.11	0.00	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	166.68	14.72	2.55	2.16	0.59	0.79	0.20	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	78.16	0.63	0.95	0.95	0.00	0.32	0.32	0.32
Preadipocyte - breast, donor1	11467-119B9	60.40	0.75	1.13	0.56	0.19	0.38	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	37.72	1.44	1.96	1.83	0.39	0.00	0.00	0.39
Preadipocyte - breast, donor2	11328-117E5	96.36	1.58	2.93	0.45	0.45	0.23	0.23	0.68
Preadipocyte - omental, donor1	11468-119C1	69.58	0.96	1.39	1.07	0.64	0.32	0.11	0.32
Preadipocyte - omental, donor2	11329-117E6	75.07	1.31	1.31	1.31	0.87	0.87	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	91.68	1.86	2.01	1.00	1.00	1.15	0.14	0.72
Preadipocyte - perirenal, donor1	11469-119C2	71.85	0.00	2.95	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	108.41	2.15	2.76	6.45	1.84	1.23	0.00	1.84
Preadipocyte - subcutaneous, donor2	11356-117H6	121.65	1.24	2.83	5.31	1.95	1.42	0.71	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	124.99	1.36	5.28	1.53	1.87	0.51	1.19	2.55
Preadipocyte - visceral, donor1	11280-116I2	108.52	1.40	3.73	5.31	1.49	0.65	0.56	1.30
Preadipocyte - visceral, donor2	11357-117H7	89.74	1.84	3.22	4.60	1.84	0.92	1.38	2.30
Preadipocyte - visceral, donor3	11429-118G7	107.73	0.63	3.24	2.93	1.04	0.21	0.52	1.25
Prostate Epithelial Cells (polarized), donor1	11253-116F2	81.76	5.73	1.66	0.45	0.75	1.36	0.00	1.21
Prostate Epithelial Cells, donor2	11331-117E8	52.41	3.11	3.93	1.49	0.41	0.41	0.14	0.27
Prostate Epithelial Cells, donor3	11404-118D9	111.76	0.49	1.47	0.18	0.31	0.00	0.12	0.12
Prostate Stromal Cells, donor1	11254-116F3	95.90	1.94	2.62	2.51	1.94	0.34	0.34	1.37
Prostate Stromal Cells, donor2	11332-117E9	119.05	0.90	3.94	3.94	0.54	1.08	0.18	2.51
Prostate Stromal Cells, donor3	11405-118E1	97.81	1.56	5.94	1.46	1.04	0.31	0.21	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	184.32	3.28	3.28	0.00	0.73	0.36	0.00	1.46
Renal Cortical Epithelial Cells, donor2	11596-120H3	104.73	7.00	3.19	4.57	0.35	0.28	0.07	0.62
Renal Epithelial Cells, donor1	11517-119H5	266.80	7.61	1.52	8.62	2.54	3.04	0.00	3.55
Renal Epithelial Cells, donor2	11597-120H4	233.31	9.25	5.69	4.98	1.42	3.56	0.71	3.56
Renal Epithelial Cells, donor3	11678-122H4	104.49	5.50	2.22	2.65	0.74	0.53	0.00	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	176.34	2.72	2.72	4.09	0.68	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	138.27	2.43	2.29	2.96	0.94	1.35	0.13	1.08
Renal Glomerular Endothelial Cells, donor3	11675-122H1	99.68	5.99	2.00	3.77	1.33	1.55	0.22	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	192.98	9.98	2.66	0.67	2.66	1.33	0.00	1.33
Renal Mesangial Cells, donor1	11518-119H6	175.41	6.82	5.72	5.50	0.88	1.32	0.22	1.10
Renal Mesangial Cells, donor2	11598-120H5	210.67	6.27	5.02	4.39	0.63	0.63	0.63	1.88
Renal Mesangial Cells, donor3	11679-122H5	153.41	5.83	2.22	1.66	1.11	1.11	0.28	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	199.71	5.64	1.61	5.10	0.54	1.07	0.27	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	164.88	1.69	0.84	2.11	0.42	0.00	0.42	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	174.53	5.21	4.05	4.82	0.96	1.93	0.19	1.54
Retinal Pigment Epithelial Cells, donor0	11215-116A9	120.31	3.11	3.37	9.33	0.52	0.78	0.00	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	123.08	6.25	2.27	5.40	0.28	1.42	0.28	1.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	128.64	2.06	1.03	8.23	1.03	0.00	0.00	3.09
Retinal Pigment Epithelial Cells, donor3	11689-122I6	81.29	2.26	0.50	1.00	0.50	1.00	0.50	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	132.70	0.94	1.74	0.40	0.00	0.40	0.00	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	95.59	0.89	2.68	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	48.43	2.20	0.00	0.55	0.55	0.55	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	140.37	8.12	5.80	0.58	1.74	1.74	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	62.15	2.73	2.60	1.30	0.52	1.04	0.52	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	75.27	3.08	2.98	0.30	0.40	1.49	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	65.25	2.90	3.57	0.56	0.67	0.45	0.45	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	74.30	5.71	2.73	0.99	0.74	0.50	0.50	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	80.77	2.80	1.98	1.40	0.58	1.28	0.70	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	78.12	3.93	2.31	1.16	0.92	0.46	0.46	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	66.95	2.88	2.05	0.82	0.68	1.10	0.27	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	73.37	3.93	3.18	1.21	0.76	0.76	0.15	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	65.23	3.58	2.69	1.08	0.36	0.54	0.00	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	64.27	2.01	2.73	0.86	0.29	0.72	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	72.12	3.11	2.25	0.86	0.43	1.72	0.32	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	81.87	2.43	3.10	1.11	0.66	1.33	1.11	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	59.84	3.25	2.87	0.57	0.38	0.76	0.38	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	80.03	3.54	4.01	0.93	0.47	0.75	0.47	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	51.49	3.19	1.69	0.38	0.56	0.38	0.75	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	75.91	3.32	2.79	0.40	0.93	0.93	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	82.06	3.60	2.92	1.07	0.19	0.97	0.39	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	76.00	1.91	2.86	0.95	0.57	0.95	0.19	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	65.57	2.78	3.31	0.64	0.64	1.17	0.11	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	69.52	3.36	2.52	0.00	0.28	0.84	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	72.97	3.08	1.20	0.68	1.20	0.51	0.85	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	69.65	2.37	3.10	0.55	0.55	1.09	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	75.05	4.05	1.96	0.98	0.49	0.86	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	76.83	4.03	3.22	0.67	0.54	0.81	0.27	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	60.38	3.07	3.54	0.71	0.47	0.00	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	75.60	5.16	2.98	1.39	0.60	0.79	0.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	82.78	3.74	3.04	0.94	0.70	1.87	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	72.16	2.90	2.90	0.41	0.62	1.24	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	65.92	4.42	3.98	1.11	0.66	1.77	0.88	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	88.36	3.34	2.51	0.84	1.04	1.04	0.42	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	71.33	2.96	2.42	1.21	0.67	0.94	0.00	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	93.49	2.38	2.55	0.85	0.34	0.68	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	85.99	4.82	2.70	0.58	0.77	1.74	0.58	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	68.60	3.09	3.44	2.24	0.17	0.86	0.52	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	87.79	3.57	2.88	0.82	0.82	0.41	0.55	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	76.17	3.94	2.13	0.49	0.66	1.31	0.49	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	62.72	2.90	2.56	0.34	0.17	0.51	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	93.07	4.29	3.11	0.74	1.33	1.48	1.18	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	77.57	4.00	2.93	0.27	0.53	1.07	0.53	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	63.60	1.94	2.07	0.28	0.55	0.55	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	73.81	3.33	2.38	0.48	0.24	0.95	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	97.34	4.64	2.62	0.20	0.40	1.21	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	60.84	4.52	2.73	0.09	0.19	1.41	0.28	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	73.72	3.49	1.40	0.35	0.35	0.00	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	83.71	4.84	1.21	0.91	0.30	0.00	1.21	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	66.95	6.98	2.94	0.37	0.49	0.37	0.37	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	72.63	3.20	0.87	0.44	0.58	0.58	1.16	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	86.40	0.61	1.83	0.00	0.61	2.43	0.61	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	73.54	4.52	3.01	1.21	0.30	0.30	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	78.94	3.39	1.36	0.00	0.23	0.68	0.45	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	82.07	3.29	1.80	0.30	0.90	1.20	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	56.09	3.78	1.77	0.47	0.47	0.71	0.24	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	76.63	2.77	1.71	0.64	1.07	1.07	0.64	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	75.12	3.61	1.20	0.60	1.20	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	231.33	6.02	2.26	2.63	1.50	1.50	0.38	0.56
Schwann Cells, donor2	11578-120F3	98.67	0.00	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	103.41	3.72	1.53	2.63	0.66	0.44	0.22	0.44
Sebocyte, donor1	11220-116B5	138.59	1.64	1.64	0.55	0.00	0.00	0.00	0.55
Sebocyte, donor2	11301-117B5	130.51	0.92	2.76	0.00	0.92	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	123.05	0.62	2.89	0.41	0.00	0.00	0.21	0.41
Sertoli Cells, donor1	11255-116F4	107.68	6.63	3.31	4.97	1.66	0.00	1.66	3.31
Sertoli Cells, donor2	11333-117F1	98.85	2.82	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	177.28	1.50	2.73	1.14	0.79	0.18	0.09	0.70
Skeletal Muscle Cells, donor2	11358-117H8	156.13	4.34	5.06	2.17	0.00	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	171.39	7.52	3.34	6.69	2.51	1.67	0.00	1.67
Skeletal Muscle Cells, donor4	11451-119A2	139.19	1.41	2.04	4.87	1.26	0.63	0.16	1.26
Skeletal Muscle Cells, donor5	11455-119A6	137.05	2.08	1.78	1.78	1.34	0.59	0.59	1.49
Skeletal Muscle Cells, donor6	11459-119B1	151.59	2.77	1.69	4.77	0.46	0.46	0.00	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	148.44	4.16	2.90	2.27	0.76	0.50	0.13	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	136.12	1.85	2.43	2.00	0.71	1.43	0.57	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	138.89	2.28	1.88	5.16	1.29	0.69	0.30	1.49
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	103.71	3.37	3.03	4.38	2.70	0.42	0.25	1.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	234.50	2.17	5.79	1.45	0.72	2.90	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	139.94	2.20	6.60	4.68	4.27	0.96	0.00	2.34
Skin - palm, donor1	10286-104F7	298.16	0.00	2.69	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	62.28	3.17	2.88	1.30	1.15	0.29	0.00	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	72.79	8.18	2.45	1.64	3.27	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	74.91	2.21	1.04	0.52	0.52	0.26	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	110.37	3.06	1.39	1.11	0.56	0.42	0.42	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	126.45	1.41	2.11	1.41	0.98	0.28	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	115.03	7.82	3.17	2.75	0.63	0.21	0.00	1.48
Small Airway Epithelial Cells, donor3	11406-118E2	159.94	1.72	1.42	0.75	0.30	0.22	0.15	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	95.04	3.09	5.86	2.78	2.47	0.00	0.00	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	30.90	1.11	3.78	2.00	0.44	0.67	0.00	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	125.79	2.35	7.05	2.94	2.35	1.18	0.00	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	85.97	3.76	2.87	3.54	0.88	0.66	0.22	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	123.65	2.36	3.54	7.88	1.97	0.79	0.39	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	139.83	3.86	4.64	0.77	1.55	0.00	0.00	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	119.09	2.00	3.00	1.00	0.00	3.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	112.58	2.53	4.26	2.53	0.93	0.27	0.13	1.33
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	113.49	1.99	4.88	3.99	0.89	1.33	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	201.52	5.63	7.94	4.99	2.05	1.28	0.26	1.28
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	86.28	4.56	3.26	1.63	0.98	1.30	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	80.62	2.66	2.66	0.89	0.59	0.59	0.59	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	75.31	1.57	3.13	1.28	0.57	0.85	0.43	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	150.47	2.60	3.74	1.95	1.30	1.46	0.16	1.63
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	70.02	0.00	2.13	0.61	0.30	0.30	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	122.75	1.52	3.03	3.03	1.77	0.51	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	67.33	0.00	0.00	0.00	12.24	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	169.75	4.29	3.81	3.81	0.95	0.48	0.00	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	87.89	4.28	4.28	1.33	1.18	0.15	0.29	1.33
Smooth Muscle Cells - Colonic, donor2	11320-117D6	95.78	3.66	4.74	1.94	0.43	0.86	0.22	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	102.75	2.94	2.73	2.94	0.31	0.84	0.21	0.94
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	120.34	2.78	6.50	7.27	1.55	0.62	0.31	1.39
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	187.55	3.23	12.93	5.39	1.08	4.31	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	106.69	1.20	2.09	4.18	0.60	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	183.33	4.44	4.10	5.12	0.68	0.34	0.00	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	113.87	3.61	2.59	1.26	0.39	0.55	0.00	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	75.98	3.72	6.44	2.72	0.81	0.91	0.30	0.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	98.30	0.91	5.23	2.73	0.68	0.23	0.68	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	127.40	3.02	5.43	6.04	0.60	1.81	0.00	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	164.52	3.97	5.03	9.54	2.12	2.12	0.26	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	111.85	3.60	5.06	1.46	1.07	0.80	0.00	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	110.82	2.25	5.01	1.38	0.88	0.63	0.25	1.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	100.70	0.25	3.04	0.51	0.51	0.25	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	115.94	2.11	6.63	4.07	1.96	1.06	0.45	1.66
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	118.53	0.00	2.25	3.00	1.50	0.00	0.00	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	100.79	2.58	0.00	2.58	1.29	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	110.69	4.19	4.65	7.91	0.93	0.00	0.00	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	108.55	2.02	4.54	2.52	2.52	1.51	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	90.88	0.94	4.70	3.45	0.31	0.63	0.31	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	84.37	0.88	6.49	2.95	1.47	0.29	0.59	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	147.70	2.17	3.08	4.25	1.08	1.33	0.17	1.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	99.04	0.93	2.34	0.93	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	118.01	5.32	3.17	3.17	0.86	0.72	0.29	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	167.76	5.35	2.80	4.33	0.76	1.02	1.02	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	207.21	5.08	4.32	5.45	1.32	1.32	0.19	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	98.10	3.91	2.66	2.93	0.98	1.82	0.14	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	117.30	3.02	2.35	0.75	0.50	0.17	0.08	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	117.62	2.86	2.38	0.48	0.00	0.95	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	112.79	6.61	4.16	3.43	0.49	0.00	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	103.62	2.87	4.86	2.87	2.65	0.22	0.22	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	128.44	1.17	2.34	2.34	1.76	0.00	0.29	1.46
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	79.88	0.39	2.14	1.36	0.00	0.39	0.00	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	68.49	0.26	3.44	2.12	0.26	0.00	0.79	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	48.73	0.00	2.98	0.00	0.37	0.37	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	65.40	0.72	5.39	1.44	0.36	0.36	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	46.84	0.57	7.10	2.27	0.85	0.57	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	102.80	1.58	0.39	3.15	1.18	0.79	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	67.55	0.51	2.54	0.25	0.25	0.51	0.51	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	70.28	0.80	2.40	0.40	0.40	0.00	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	83.18	0.42	4.60	0.00	0.84	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	92.13	1.38	3.21	0.46	0.92	0.92	0.00	0.92
Synoviocyte, donor1	11291-117A4	99.31	2.36	2.69	3.03	1.51	0.34	0.17	0.34
Synoviocyte, donor2	11368-117I9	122.03	0.34	5.20	1.01	1.51	0.50	0.84	0.34
Synoviocyte, donor3	11440-118H9	109.25	0.22	2.68	0.22	0.00	0.22	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	185.45	1.43	3.93	3.57	0.71	1.79	0.00	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	239.83	5.95	0.00	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	184.08	3.01	2.08	2.08	0.93	1.16	0.69	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	142.44	2.44	1.22	0.43	0.50	0.00	0.07	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	144.96	1.16	2.71	0.39	0.39	0.39	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	154.05	3.44	3.44	0.00	1.15	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	145.54	0.86	1.48	0.25	0.12	1.11	0.00	0.12
Urethra, donor2	10319-105A4	169.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	125.66	5.05	1.86	1.06	1.59	0.53	0.00	0.53
Urothelial Cells, donor2	11600-120H7	116.96	3.61	1.60	0.80	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	132.48	2.29	2.29	0.23	0.23	0.00	0.23	0.23
Urothelial cells, donor0	11216-116B1	139.31	4.46	2.67	1.56	0.22	0.00	0.22	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	118.34	0.89	1.78	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	141.53	1.43	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	101.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	111.22	0.00	0.00	0.00	0.00	0.00	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	109.81	0.00	0.58	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	103.08	0.00	1.04	0.00	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	113.81	0.00	0.92	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	94.03	0.00	0.91	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	120.28	5.43	2.22	1.23	1.11	1.97	0.00	0.99
Wilms' tumor cell line:HFWT	10597-108E3	183.05	1.76	2.64	0.88	0.00	0.88	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	213.12	0.84	1.68	0.84	0.56	1.96	0.00	0.28
achilles tendon, donor2	10292-104G4	138.46	0.00	2.07	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	167.76	0.76	0.76	0.76	0.51	3.31	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	142.32	2.32	1.39	0.23	0.46	1.39	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	204.42	12.46	1.31	0.83	0.71	0.95	0.24	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	95.78	3.27	1.63	0.54	0.54	1.90	0.27	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	141.67	6.75	1.12	1.41	0.28	3.09	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	154.59	4.86	3.60	0.63	0.21	1.27	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	140.46	18.51	5.17	0.82	0.54	4.36	1.09	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	127.79	6.17	5.73	0.00	1.32	0.88	0.44	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	117.20	3.68	2.04	0.00	0.00	2.04	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	218.61	3.11	1.55	0.00	0.00	0.78	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	156.22	1.10	0.74	0.37	0.37	1.47	0.37	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	351.05	19.50	0.00	3.90	3.90	23.40	7.80	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	133.15	6.04	2.32	1.16	0.70	2.79	0.46	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	160.00	0.78	1.81	0.52	0.26	0.26	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	176.81	2.05	3.21	0.58	0.00	0.88	0.29	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	154.76	0.00	0.46	0.46	0.00	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	156.28	2.06	3.29	0.00	0.41	0.82	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	119.40	0.92	1.53	0.00	0.00	1.84	3.99	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	157.03	0.85	2.13	0.43	0.00	0.85	16.64	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	133.75	0.30	3.34	0.30	0.00	1.52	23.05	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	134.07	1.93	1.93	0.48	0.48	0.96	13.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	135.43	0.89	2.00	0.00	0.00	0.45	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	181.12	11.34	5.67	12.34	12.01	4.00	4.00	5.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	457.12	24.16	9.29	1.86	5.57	7.43	1.86	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	154.43	14.31	3.01	2.64	0.75	1.51	1.51	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	238.56	9.59	5.67	1.31	2.18	4.80	0.44	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	457.37	131.21	15.00	24.37	13.12	20.62	3.75	5.62
adenocarcinoma cell line:IM95m	10796-110I4	158.49	1.41	0.94	0.00	0.00	0.47	0.00	0.47
adipose tissue, adult, pool1	10010-101C1	73.06	0.00	0.00	0.00	0.31	0.00	0.31	0.16
adipose, donor1	10184-103D4	164.78	1.17	1.17	0.59	1.76	1.76	0.59	1.17
adipose, donor2	10185-103D5	101.38	2.43	0.41	0.41	0.00	0.81	0.00	0.41
adipose, donor3	10186-103D6	103.47	4.90	0.00	1.09	0.82	0.54	0.00	1.09
adipose, donor4	10187-103D7	89.28	9.53	1.73	0.87	0.00	0.00	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	171.23	4.73	4.89	1.42	0.95	0.95	0.16	0.63
adrenal gland, adult, pool1	10081-102A9	156.42	0.00	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	96.85	0.00	0.27	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	227.96	2.50	2.14	1.07	0.71	0.71	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	116.85	2.32	1.62	0.00	0.00	0.00	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	143.36	3.38	1.69	0.00	0.34	0.68	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	135.81	2.36	0.88	0.00	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	90.12	0.00	5.93	0.00	2.37	1.19	28.46	0.00
amygdala, adult, donor10252	10151-102I7	122.88	0.81	2.64	0.61	2.23	0.41	40.76	1.42
amygdala, newborn, donor10223	10360-105E9	39.70	0.00	1.94	1.29	4.84	0.97	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	91.93	5.48	0.76	0.25	0.38	0.13	0.00	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	163.04	0.00	0.66	0.22	0.00	0.22	0.22	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	130.94	1.67	0.67	0.00	1.00	2.00	0.00	0.67
aorta, adult, pool1	10052-101G7	230.06	0.00	1.18	0.20	0.00	0.00	0.39	0.39
appendix, adult	10189-103D9	150.20	1.16	0.78	0.00	0.00	1.55	0.78	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	190.20	12.38	3.78	0.34	0.00	1.72	0.00	0.69
artery, adult	10190-103E1	232.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	89.24	2.75	0.14	0.00	0.14	0.29	0.29	0.29
b cell line:RPMI1788	10427-106D4	148.85	3.12	0.89	0.30	0.15	0.30	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	87.12	3.61	3.05	2.50	2.22	0.00	0.28	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	171.17	1.98	0.89	0.79	0.20	0.30	0.20	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	105.45	0.67	1.17	0.17	0.33	0.17	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	167.21	0.56	2.80	0.00	0.56	0.56	0.56	0.00
bladder, adult, pool1	10011-101C2	120.48	0.22	0.11	0.00	0.00	0.22	0.00	0.11
blood, adult, pool1	10053-101G8	155.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	125.03	0.86	0.86	0.00	0.00	0.00	0.86	0.86
bone marrow, adult	10192-103E3	89.75	2.70	0.67	0.67	0.67	2.02	0.00	0.67
brain, adult, donor1	10084-102B3	156.84	0.00	2.05	1.03	0.00	2.05	6.15	0.00
brain, adult, pool1	10012-101C3	115.03	0.45	2.45	0.45	1.45	0.45	1.89	0.56
brain, fetal, pool1	10085-102B4	98.84	0.00	0.00	0.00	2.67	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	246.12	1.98	4.96	0.66	0.66	0.66	0.33	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	126.45	3.87	2.75	0.12	0.25	0.37	0.00	0.62
breast, adult, donor1	10080-102A8	100.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	211.65	3.18	2.16	0.13	0.51	0.76	0.25	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	168.83	4.95	1.55	0.93	0.31	0.31	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	196.15	6.68	6.22	0.46	2.99	1.84	0.46	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	126.85	0.73	3.39	0.24	0.24	0.48	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	112.84	11.75	1.88	0.00	0.00	0.47	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	226.09	4.27	1.09	0.33	0.77	0.55	0.11	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	138.48	9.19	1.27	0.32	0.32	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	171.95	7.99	4.53	1.33	1.60	1.86	0.00	0.80
caudate nucleus - adult, donor10196	10177-103C6	101.32	0.00	4.61	0.00	2.30	0.00	2.30	1.15
caudate nucleus, adult, donor10252	10164-103B2	127.34	1.84	2.01	1.00	2.84	1.84	12.88	1.67
caudate nucleus, adult, donor10258	10379-105H1	123.79	0.76	1.53	0.76	3.06	1.53	2.29	0.76
caudate nucleus, newborn, donor10223	10354-105E3	33.33	2.20	0.37	1.46	3.30	0.00	0.00	2.20
cerebellum - adult, donor10196	10173-103C2	177.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	147.32	0.00	1.71	0.64	0.21	0.21	0.21	0.43
cerebellum, adult, pool1	10083-102B2	144.88	0.00	0.69	0.34	0.34	1.38	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	88.01	1.66	0.83	1.66	0.00	1.66	0.83	0.83
cerebral meninges, adult	10188-103D8	153.30	0.76	2.52	0.25	2.77	0.50	6.56	1.76
cerebrospinal fluid, donor2	10294-104G6	144.72	0.00	2.19	1.46	0.00	0.00	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	195.11	1.29	2.44	0.14	0.14	0.29	0.14	0.43
cervical cancer cell line:ME-180	10553-107I4	97.61	0.33	0.33	0.17	0.33	0.33	0.33	0.50
cervix, adult, pool1	10013-101C4	123.89	0.31	1.36	0.84	0.31	0.10	0.10	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	95.17	1.53	0.56	0.28	0.56	0.28	0.14	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	219.45	1.31	1.31	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	124.15	1.37	1.12	0.37	0.12	0.25	0.00	0.25
choriocarcinoma cell line:SCH	10785-110H2	99.19	1.60	0.49	0.25	0.25	0.37	0.25	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	124.28	1.19	3.56	0.00	0.00	0.47	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	105.71	3.99	1.14	0.00	0.28	0.00	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	116.43	3.88	4.18	1.59	0.89	0.00	0.50	1.09
chorionic membrane cells, donor3	12240-129G8	102.75	1.65	0.55	0.00	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	132.28	5.05	1.01	0.00	1.01	6.06	0.00	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	145.42	1.54	1.92	0.58	0.96	1.15	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	258.91	9.29	4.01	1.48	0.63	3.17	2.32	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	124.55	0.77	3.34	0.51	0.26	2.57	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	143.19	0.73	1.45	0.73	0.24	1.45	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	129.70	0.61	3.46	1.63	0.61	1.43	0.00	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	114.84	0.59	3.83	0.88	0.29	0.59	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	146.47	18.50	3.65	6.52	0.52	1.82	1.04	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	166.86	6.86	2.06	0.69	0.23	0.91	0.46	0.91
clear cell carcinoma cell line:TEN	10636-108I6	169.69	0.35	1.39	0.52	0.17	1.39	0.35	0.52
colon carcinoma cell line:CACO-2	10513-107D9	55.46	4.58	1.65	0.37	0.55	1.10	0.00	0.37
colon carcinoma cell line:COLO-320	10420-106C6	161.53	0.76	1.14	0.38	0.00	0.76	0.00	0.00
colon, adult, donor1	10082-102B1	189.21	0.00	0.00	0.00	0.00	2.38	0.00	0.00
colon, adult, pool1	10014-101C5	153.93	0.59	2.47	0.12	0.24	0.24	0.12	0.12
colon, fetal, donor1	10070-101I7	190.96	0.00	1.24	0.62	0.00	1.24	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	339.18	22.92	9.17	0.00	0.00	13.75	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	300.44	25.04	0.00	0.00	0.00	0.00	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	79.04	0.42	2.97	1.27	1.27	0.00	0.42	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	107.16	2.72	1.96	1.51	3.02	0.75	0.30	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	110.69	2.26	2.54	1.55	2.26	1.13	0.14	0.85
corpus callosum, adult, pool1	10042-101F6	146.50	0.22	1.66	0.11	0.55	0.22	3.21	0.22
cruciate ligament, donor2	10295-104G7	136.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	202.25	0.80	0.80	0.00	1.61	0.00	0.00	0.00
diencephalon, adult	10193-103E4	114.71	0.48	4.08	1.44	1.20	0.72	2.16	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	361.41	2.53	2.07	0.46	0.00	4.59	0.69	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	240.28	2.56	2.82	0.00	0.51	0.00	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	116.51	1.69	8.43	2.17	1.44	0.72	0.00	1.93
ductus deferens, adult	10196-103E7	135.55	0.00	0.50	0.50	0.00	0.00	0.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	211.71	2.88	1.44	1.44	2.88	4.32	0.00	4.32
duodenum, fetal, donor1, tech_rep2	10071-101I8	155.22	1.47	0.74	0.74	0.00	4.41	0.74	1.47
dura mater, adult, donor1	10041-101F5	133.63	0.33	0.50	0.50	0.33	0.08	0.25	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	136.35	2.66	1.55	18.65	2.66	6.00	0.44	2.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	130.40	4.59	1.58	4.16	1.29	1.43	0.00	1.86
embryonic pancreas cell line:1B2C6	10604-108F1	257.75	0.62	3.70	0.00	0.00	1.23	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	122.30	0.61	3.03	0.61	0.30	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	213.96	0.93	4.32	0.93	0.31	0.93	0.00	0.62
embryonic pancreas cell line:2C6	10603-108E9	295.53	0.00	0.00	1.31	3.94	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	231.96	0.00	5.70	0.00	1.01	0.34	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	135.56	1.27	2.36	0.72	0.54	0.18	0.18	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	102.12	4.50	4.99	0.32	0.96	0.00	0.16	1.13
epidermoid carcinoma cell line:A431	10426-106D3	131.06	0.89	1.00	0.56	0.22	0.22	0.22	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	102.18	3.52	2.86	1.43	0.33	1.21	0.11	0.33
epididymis, adult	10197-103E8	104.86	0.21	1.26	0.21	0.42	0.21	0.00	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	124.90	0.89	1.95	0.71	1.06	0.89	0.18	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	94.38	3.15	3.54	0.39	0.39	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	142.58	0.13	2.62	0.66	0.00	1.97	0.26	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	153.34	0.20	1.67	0.30	0.20	1.28	0.30	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	165.02	0.45	3.58	0.22	0.11	1.23	0.22	0.56
esophagus, adult, pool1	10015-101C6	115.10	0.32	1.06	0.11	0.00	0.42	0.42	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	159.05	8.77	8.02	8.39	9.14	21.54	2.25	2.50
eye - muscle inferior rectus, donor1	10272-104E2	214.90	0.00	2.41	0.00	0.00	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	166.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	251.51	0.00	5.95	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	207.52	1.15	1.15	0.00	1.15	3.44	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	160.31	2.91	1.46	1.46	1.46	2.91	1.46	0.00
eye, fetal, donor1	10054-101G9	125.34	1.27	0.76	1.53	0.51	0.51	0.25	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	140.66	1.67	1.28	0.26	0.00	0.13	0.51	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	227.92	3.80	2.37	2.85	1.90	3.56	0.47	1.90
frontal lobe, adult, pool1	10040-101F4	132.01	0.19	3.75	1.13	3.94	0.19	5.82	1.03
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	168.44	5.40	1.50	0.60	0.90	1.50	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	69.03	1.46	1.19	1.10	0.18	0.18	0.00	0.00
gall bladder, adult	10198-103E9	130.37	0.00	1.21	0.48	0.48	0.00	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	187.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	148.65	0.00	0.75	0.37	0.00	0.00	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	132.86	0.63	2.11	0.21	0.42	0.42	0.21	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	129.59	2.32	1.35	0.58	0.19	0.00	0.19	0.58
gastric cancer cell line:AZ521	10549-107H9	123.13	5.74	2.79	0.49	0.98	0.66	0.00	0.98
gastric cancer cell line:GSS	10560-108A2	165.66	2.75	1.83	0.92	0.00	0.92	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	44.32	2.06	0.23	0.00	0.46	0.23	0.00	0.23
giant cell carcinoma cell line:LU65	10487-107B1	34.31	0.23	0.69	0.00	0.00	0.11	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	306.51	4.76	2.66	4.48	1.12	0.14	0.56	1.82
glassy cell carcinoma cell line:HOKUG	10688-109F4	133.19	1.50	2.99	0.75	0.75	0.50	0.00	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	113.15	0.32	3.59	0.21	0.53	0.84	0.74	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	140.58	0.00	4.63	0.70	0.98	0.98	0.56	0.70
glioblastoma cell line:T98G	10485-107A8	105.63	1.77	3.20	1.77	1.55	0.44	0.11	0.99
glioma cell line:GI-1	10413-106B8	64.43	4.10	1.46	0.88	0.59	0.88	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	126.83	1.46	3.64	0.00	1.46	0.73	3.64	0.00
globus pallidus, adult, donor10252	10161-103A8	167.20	0.49	1.95	0.24	0.24	0.24	1.22	0.00
globus pallidus, adult, donor10258	10367-105F7	110.91	1.37	1.37	0.00	1.37	1.37	4.11	1.37
globus pallidus, newborn, donor10223	10364-105F4	43.70	0.00	0.53	1.60	1.60	0.53	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	430.70	9.79	7.34	4.89	0.00	4.89	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	404.35	0.00	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	303.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	16.32	0.64	6.08	0.00	0.64	0.32	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	117.07	3.21	1.84	0.92	0.46	0.46	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	95.57	2.29	3.20	1.83	1.37	0.00	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	99.19	1.29	6.44	0.64	1.93	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	63.24	1.44	1.44	1.44	1.44	1.44	0.00	1.44
hIPS, biol_rep2	14381-156B7	106.31	6.86	2.06	0.69	0.00	0.00	0.00	2.06
hIPS, biol_rep3	14382-156B8	144.55	0.00	8.83	0.00	1.10	0.00	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	138.79	5.17	0.86	0.29	0.86	0.86	0.29	0.00
heart - mitral valve, adult	10205-103F7	126.46	0.00	0.60	0.00	0.00	0.60	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	161.85	0.00	1.31	0.00	0.26	0.78	0.26	0.52
heart - tricuspid valve, adult	10207-103F9	114.07	0.00	0.00	0.00	0.00	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	168.14	1.02	0.61	0.00	0.00	0.61	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	186.94	0.00	1.70	0.00	0.00	0.00	0.85	0.00
heart, adult, pool1	10016-101C7	160.75	0.23	0.46	0.00	0.00	0.23	0.00	0.00
heart, fetal, pool1	10046-101G1	134.61	0.92	0.62	0.51	0.21	0.41	0.10	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	137.60	2.47	1.85	0.31	0.62	0.00	0.00	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	445.94	4.76	3.57	0.00	1.19	5.95	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	127.40	14.14	3.98	2.76	1.77	3.43	0.55	2.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	118.83	14.81	3.52	3.88	1.58	4.13	0.61	1.58
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	121.87	19.10	3.54	4.04	1.52	2.83	0.00	2.83
hepatoma cell line:Li-7	10484-107A7	194.96	2.22	0.67	0.22	0.56	0.67	0.11	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	190.95	4.22	1.11	0.20	0.20	1.31	0.30	0.00
hippocampus - adult, donor10196	10169-103B7	107.88	0.00	4.73	0.00	4.73	0.95	13.25	0.00
hippocampus, adult, donor10252	10153-102I9	135.73	0.20	1.43	0.20	2.45	0.61	14.29	1.02
hippocampus, adult, donor10258	10374-105G5	116.52	0.50	5.98	0.50	1.99	0.50	1.49	2.49
hippocampus, newborn, donor10223	10363-105F3	29.26	0.00	0.70	1.06	0.70	0.35	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	97.04	14.04	1.83	0.61	0.00	1.22	1.22	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	85.02	13.35	0.59	2.16	1.18	0.20	0.00	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	76.68	16.76	1.27	0.51	0.76	1.02	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	99.80	2.82	2.82	0.00	0.56	0.56	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	116.71	2.58	0.52	0.26	0.26	0.77	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	86.55	3.80	1.14	1.14	0.38	1.52	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	89.34	4.38	0.88	0.58	0.29	0.88	0.29	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	99.74	3.23	1.08	0.43	0.22	0.86	0.22	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	93.01	4.17	0.42	1.25	0.42	2.09	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	104.43	7.34	2.13	1.18	0.95	3.55	0.47	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	126.00	6.27	1.45	1.45	0.96	2.89	0.16	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	100.32	6.73	2.02	2.02	0.67	1.35	0.00	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	75.74	9.55	0.16	0.94	0.47	0.31	0.00	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	90.89	14.25	0.98	0.00	0.00	0.49	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	73.31	15.71	0.87	1.75	0.00	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	104.81	2.67	0.76	0.00	0.38	0.76	0.00	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	108.15	2.62	0.44	0.00	0.00	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	84.46	2.50	1.50	0.00	1.00	2.50	0.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	88.17	2.64	1.13	0.19	0.00	1.70	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	82.30	9.09	0.91	0.45	0.00	0.91	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	83.32	4.39	2.82	0.31	0.63	2.19	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	97.98	6.53	1.63	1.47	0.82	0.82	0.16	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	94.93	4.94	1.74	1.16	0.87	1.74	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	90.57	4.48	3.29	1.79	1.20	1.20	0.00	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	91.82	13.49	1.11	0.55	0.74	0.00	0.00	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	98.14	12.55	2.00	1.14	1.14	0.86	0.29	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	101.67	18.37	1.63	0.82	1.22	2.04	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	110.91	4.58	1.41	0.35	0.70	0.35	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	100.41	5.07	0.32	0.00	0.32	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	103.50	3.93	0.61	0.61	0.00	0.30	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	83.26	4.14	1.03	1.03	0.52	1.03	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	102.28	6.64	0.66	0.66	0.66	2.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	85.94	7.44	1.28	1.03	0.51	1.03	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	105.84	7.16	0.77	1.02	2.05	2.81	0.26	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	107.53	6.06	3.03	3.03	3.03	1.51	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	94.43	8.07	1.68	1.34	1.34	1.01	0.34	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	96.60	12.08	1.69	0.48	1.21	0.72	0.24	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	79.33	12.48	0.89	1.78	0.89	0.00	0.00	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	101.46	11.22	2.44	0.49	1.46	0.98	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	103.30	2.14	0.61	0.92	0.61	0.31	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	302.55	9.76	0.00	0.00	3.25	3.25	9.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	118.48	2.98	0.00	0.00	0.00	0.99	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	94.14	6.02	2.19	1.09	0.55	1.64	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	93.73	2.90	1.45	0.36	0.72	0.00	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	87.54	3.56	0.71	1.07	0.36	0.36	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	83.54	2.39	2.39	1.19	1.19	3.58	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	100.21	5.01	1.08	2.44	0.68	2.84	0.14	0.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	94.83	4.58	1.62	1.35	2.16	1.89	0.00	0.27
immature langerhans cells, donor1	11904-125F5	159.82	2.42	2.66	0.24	0.24	0.24	0.24	0.00
immature langerhans cells, donor2	11905-125F6	158.43	3.17	2.38	0.00	0.79	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	133.24	0.66	3.69	0.85	4.35	0.57	19.87	1.99
keratoacanthoma cell line:HKA-1	10791-110H8	95.27	0.00	1.95	0.33	0.00	0.33	0.00	0.00
kidney, adult, pool1	10017-101C8	146.19	0.50	3.20	1.00	0.40	0.80	0.10	0.30
kidney, fetal, pool1	10045-101F9	123.08	1.63	0.57	0.35	0.07	0.00	0.00	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	202.24	7.39	5.82	1.70	1.28	0.57	0.14	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	140.45	2.35	2.76	0.83	0.41	0.41	0.00	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	161.85	2.57	1.28	0.18	0.73	1.47	0.37	0.55
left atrium, adult, donor1	10079-102A7	138.94	0.00	1.09	0.00	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	120.35	0.00	0.00	0.00	0.00	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	152.40	1.09	5.20	2.19	2.19	0.82	0.00	1.92
leiomyoma cell line:10964C	10569-108B2	68.62	0.72	6.11	2.16	1.08	0.00	2.16	1.08
leiomyoma cell line:15242A	10570-108B3	58.15	1.09	5.43	2.72	1.63	0.00	1.63	0.00
leiomyoma cell line:15425	10571-108B4	66.05	0.24	5.83	1.94	0.49	0.49	2.91	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	76.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	146.38	1.05	7.32	1.05	0.00	7.32	0.00	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	181.34	6.02	4.49	2.72	0.94	1.30	0.71	0.12
liposarcoma cell line:KMLS-1	10782-110G8	105.91	3.75	3.75	3.44	1.25	0.94	2.03	2.19
liposarcoma cell line:SW 872	10726-110A6	127.20	4.51	3.17	2.44	0.85	0.97	0.24	1.10
liver, adult, pool1	10018-101C9	148.45	0.16	2.11	0.00	0.00	0.16	0.16	0.16
liver, fetal, pool1	10086-102B5	117.59	1.88	0.94	0.00	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	136.64	0.73	2.19	0.87	0.87	1.46	1.90	0.44
locus coeruleus, adult, donor10252	10165-103B3	142.66	0.92	2.40	2.03	0.74	0.92	1.66	0.18
locus coeruleus, adult, donor10258	10375-105G6	86.62	0.28	3.67	0.28	0.56	1.69	1.41	0.28
locus coeruleus, newborn, donor10223	10362-105F2	36.59	0.84	0.42	0.00	1.68	0.42	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	144.48	1.52	1.80	0.42	0.42	0.28	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	130.30	0.00	0.69	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	123.64	2.24	1.19	0.26	0.26	0.53	0.00	0.00
lung, adult, pool1	10019-101D1	111.87	0.12	0.59	0.35	0.12	0.12	0.35	0.12
lung, fetal, donor1	10068-101I5	102.75	0.57	0.57	0.29	0.00	0.57	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	135.17	0.46	0.00	0.00	0.00	0.00	0.46	0.00
lymph node, adult, donor1	10077-102A5	132.07	0.47	0.47	0.00	0.00	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	174.47	2.85	0.44	0.00	0.00	0.44	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	121.19	0.15	0.75	0.00	0.00	0.91	0.30	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	93.44	1.70	0.00	0.00	0.00	0.85	0.00	0.85
mature adipocyte, donor1	12231-129F8	149.62	0.00	0.00	0.00	0.00	0.44	0.00	0.44
mature adipocyte, donor2	12232-129F9	128.04	0.00	0.42	0.00	0.00	0.21	0.21	0.00
mature adipocyte, donor3	12233-129G1	105.73	0.00	0.95	0.00	0.24	0.00	0.00	0.24
mature adipocyte, donor4	12234-129G2	124.50	0.00	0.00	0.26	0.00	0.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	255.65	10.01	2.38	0.00	0.24	0.71	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	170.33	0.00	2.26	1.13	1.13	0.00	2.26	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	143.08	0.18	2.57	0.55	1.66	0.18	2.76	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	163.29	0.95	6.35	0.00	2.22	2.22	1.91	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	35.40	0.85	2.56	5.12	3.84	0.85	0.85	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	170.10	0.34	5.06	1.52	4.89	1.01	9.96	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	143.68	0.21	2.55	0.64	1.49	0.00	4.46	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	73.20	0.00	5.78	3.85	11.56	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	100.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	32.30	1.79	1.79	2.51	3.95	1.08	0.00	1.08
medulla oblongata - adult, donor10196	10174-103C3	117.47	0.65	3.89	1.30	0.00	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	123.69	0.31	1.08	0.31	0.15	0.15	1.24	0.46
medulla oblongata, adult, pool1	10038-101F2	117.22	0.65	2.12	1.22	0.33	0.73	0.73	0.49
medulla oblongata, newborn, donor10223	10361-105F1	61.10	0.00	0.69	0.69	1.39	0.00	0.00	0.69
medulloblastoma cell line:D283 Med	10838-111E1	177.79	2.88	0.22	0.44	1.11	0.22	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	152.84	3.42	1.71	1.22	0.61	1.59	0.37	0.37
melanoma cell line:COLO 679	10514-107E1	104.22	0.14	1.58	0.43	0.29	0.86	0.14	0.57
melanoma cell line:G-361	10465-106H6	86.05	0.54	0.81	0.27	1.09	0.00	0.00	0.54
meningioma cell line:HKBMM	10691-109F7	124.82	1.81	0.36	0.18	0.00	0.18	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	205.31	4.41	4.41	0.88	0.00	1.76	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	142.83	4.93	1.81	0.52	0.78	0.52	0.26	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	123.05	2.61	3.99	5.37	2.30	0.46	1.69	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	109.43	2.54	3.64	1.82	0.55	0.18	0.18	1.64
mesenchymal precursor cell - adipose, donor3	11749-123G3	76.61	0.83	3.31	1.66	1.66	0.41	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	77.82	0.56	6.32	1.26	0.42	0.00	0.28	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	77.41	0.77	4.81	1.16	0.39	0.19	0.39	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	78.43	0.69	4.86	0.69	0.69	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	81.53	0.00	3.95	1.03	0.34	0.34	0.51	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	71.08	0.23	2.53	0.58	1.15	0.00	0.00	1.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	103.32	2.65	5.31	4.64	1.46	0.66	0.40	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	91.42	1.62	2.97	3.11	0.95	0.41	0.41	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	77.39	2.28	4.13	2.42	1.28	0.85	0.14	1.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	75.09	1.65	2.31	0.00	0.99	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	97.14	3.18	4.01	2.08	1.94	0.28	0.42	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	82.73	2.09	2.79	3.49	1.40	0.35	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	76.36	2.65	4.29	2.86	2.25	0.61	0.20	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	66.14	2.52	2.52	0.72	0.36	0.36	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	77.79	3.83	2.48	0.62	0.72	0.10	0.00	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	46.05	2.05	4.56	3.88	0.91	0.23	0.00	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	75.52	5.03	5.03	5.45	1.26	1.68	0.84	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	86.37	2.39	4.33	2.24	0.60	0.60	0.30	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	88.14	4.03	3.94	1.66	0.70	0.44	0.18	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	75.84	1.84	0.74	0.74	1.10	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	64.96	2.00	3.15	1.43	2.29	0.29	0.86	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	113.25	3.79	0.84	2.53	1.68	1.68	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	118.28	1.37	5.94	2.28	0.46	0.46	0.46	2.74
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	111.01	2.05	3.58	3.33	1.53	0.51	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	110.72	2.88	3.40	2.36	0.79	0.52	1.05	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	94.27	1.54	3.08	2.77	0.62	0.31	0.92	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	98.85	1.41	3.29	3.29	0.94	0.47	1.41	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	110.68	3.05	6.09	4.06	1.69	0.34	0.68	1.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	116.71	3.54	4.72	3.54	1.18	0.39	0.39	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	89.90	2.32	3.24	1.39	0.93	0.46	0.00	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	131.52	3.17	1.73	4.04	1.15	0.87	1.15	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	119.58	1.12	4.69	4.69	1.12	0.45	1.78	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	110.32	0.72	3.12	2.40	2.40	0.96	0.72	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	129.07	0.73	5.87	3.67	0.73	1.47	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	101.37	1.34	3.36	3.36	2.01	1.01	1.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	103.57	2.05	2.46	3.68	2.46	0.41	0.41	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	101.38	3.01	1.72	2.15	1.72	1.29	0.00	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	147.66	2.73	2.73	2.73	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	98.13	5.16	0.00	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	109.78	1.62	4.22	2.27	1.30	0.65	0.65	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	130.95	1.45	1.45	2.91	5.82	0.00	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	149.80	4.26	2.13	6.93	2.13	1.60	0.53	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	112.03	4.09	4.91	3.27	0.82	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	123.22	2.33	3.50	2.72	1.17	1.17	1.17	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	109.13	0.00	6.30	2.10	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	112.26	2.98	0.99	4.97	0.99	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	114.41	0.00	4.77	4.77	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	134.01	1.19	1.19	0.59	1.78	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	119.41	3.66	2.44	3.66	1.22	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	120.98	3.80	2.53	2.53	1.90	1.27	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	123.48	0.34	4.14	0.69	0.00	0.34	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	120.36	0.00	6.45	0.00	0.00	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	87.82	0.00	0.00	7.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	158.42	3.44	6.89	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	142.61	0.81	2.85	0.00	0.81	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	141.41	0.79	3.97	2.38	0.00	0.00	0.79	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	122.62	0.00	2.36	1.18	0.59	1.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	132.79	0.31	2.81	0.31	0.62	0.00	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	129.66	0.00	2.67	2.67	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	125.36	1.18	7.10	0.00	0.00	1.18	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	112.99	0.00	10.27	2.57	0.00	2.57	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	126.66	0.00	5.51	2.75	2.07	0.69	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	168.23	0.99	5.94	0.99	0.00	0.00	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	145.80	0.00	4.49	0.00	1.12	2.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	152.02	0.00	3.82	0.64	0.00	1.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	212.37	1.21	5.64	0.40	0.81	1.61	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	226.78	0.00	10.90	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	211.60	0.00	3.80	1.27	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	145.05	0.00	3.03	0.61	1.21	1.21	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	167.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	162.27	1.65	2.47	0.00	0.00	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	103.58	0.40	2.78	0.79	0.60	0.60	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	131.42	0.32	2.60	0.65	0.32	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	127.33	0.00	1.02	2.04	0.00	0.00	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	109.87	1.55	3.87	0.00	2.32	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	185.21	2.36	3.07	0.71	1.18	0.94	0.24	1.65
mesothelioma cell line:ACC-MESO-4	10494-107B8	132.52	4.63	6.49	0.46	1.16	0.70	1.16	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	98.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	72.85	0.10	0.72	0.62	0.31	0.10	0.00	0.41
mesothelioma cell line:Mero-25	10850-111F4	174.07	3.18	1.36	2.04	1.59	0.91	0.68	1.36
mesothelioma cell line:Mero-41	10851-111F5	205.85	0.98	0.98	1.71	0.98	0.73	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	123.78	1.33	1.99	1.11	0.22	0.22	0.22	0.44
mesothelioma cell line:Mero-82	10853-111F7	146.12	1.58	0.53	0.26	0.26	0.53	0.26	0.53
mesothelioma cell line:Mero-83	10854-111F8	80.34	1.36	2.04	1.87	0.17	1.02	0.17	0.17
mesothelioma cell line:Mero-84	10855-111F9	105.41	3.03	1.52	1.77	2.27	0.25	0.00	1.01
mesothelioma cell line:Mero-95	10856-111G1	175.37	7.04	3.73	1.86	1.66	1.86	0.62	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	110.16	0.66	1.16	2.98	0.50	1.33	0.17	0.33
mesothelioma cell line:NCI-H226	10846-111E9	112.94	0.72	3.44	1.63	0.90	1.81	0.36	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	117.35	0.34	2.22	0.34	0.68	0.68	0.00	0.68
mesothelioma cell line:NCI-H28	10845-111E8	91.35	2.04	2.80	0.51	0.76	0.25	1.78	0.25
mesothelioma cell line:No36	10857-111G2	106.67	0.98	2.94	0.33	0.98	1.63	0.00	0.98
mesothelioma cell line:ONE58	10858-111G3	101.88	0.54	1.63	0.54	0.00	0.27	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	102.10	0.19	1.73	0.00	0.19	0.00	0.38	0.00
migratory langerhans cells, donor2	11902-125F3	108.56	0.00	0.49	0.00	0.12	0.00	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	164.05	0.18	0.36	0.00	0.00	0.00	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	143.32	1.31	0.65	0.65	0.33	0.33	0.65	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	88.80	8.48	1.70	5.30	0.42	0.00	0.21	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	220.68	0.23	0.92	0.46	0.00	0.92	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	142.72	0.57	1.71	0.19	0.19	0.95	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	123.07	2.59	1.66	0.00	0.18	1.11	0.74	0.00
myeloma cell line:PCM6	10474-106I6	178.89	0.00	0.59	0.00	0.00	0.00	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	206.97	0.51	2.03	0.51	0.51	0.51	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	102.38	0.39	1.18	0.39	0.00	0.78	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	143.63	0.45	2.45	0.11	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	136.93	0.44	1.40	0.00	0.07	0.07	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	104.88	1.10	1.10	0.00	0.00	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	193.02	11.96	0.46	0.46	1.38	1.84	0.46	1.15
neuroblastoma cell line:NB-1	10539-107G8	183.53	12.16	2.99	1.12	1.31	2.06	0.00	1.87
neuroblastoma cell line:NBsusSR	10607-108F4	173.77	1.90	0.84	0.00	0.21	1.05	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	247.66	2.24	0.37	0.00	0.37	0.93	0.37	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	137.59	11.62	0.71	0.00	0.95	0.24	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	162.82	3.48	0.95	0.16	1.43	0.00	0.16	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	152.35	1.41	0.81	0.20	0.40	0.40	0.40	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	354.12	4.45	6.99	0.00	0.64	0.64	0.64	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	146.39	1.86	3.46	2.40	0.80	0.53	0.00	1.86
neutrophil PMN, donor1	12133-128D9	565.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	146.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	208.35	0.00	0.00	0.00	0.00	0.00	18.94	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	97.75	4.90	1.01	0.51	0.00	2.03	0.51	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	136.09	4.00	0.00	0.00	0.00	0.80	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	100.03	3.21	1.92	0.32	0.64	1.60	0.00	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	85.92	2.36	6.31	0.00	1.58	1.05	0.53	2.10
nucleus accumbens, adult, pool1	10037-101F1	128.24	0.56	4.12	1.12	3.28	0.47	6.75	1.87
occipital cortex - adult, donor10196	10172-103C1	181.31	0.00	8.24	2.06	0.00	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	169.07	0.27	3.22	0.54	1.07	0.00	1.07	0.54
occipital cortex, newborn, donor10223	10355-105E4	46.95	0.73	1.82	2.55	6.55	0.36	1.09	1.82
occipital lobe, adult, donor1	10076-102A4	157.18	0.26	4.72	0.26	1.57	0.79	2.62	0.26
occipital lobe, fetal, donor1	10073-102A1	77.67	3.00	1.72	1.72	1.29	0.00	0.00	0.43
occipital pole, adult, pool1	10036-101E9	162.81	0.16	3.55	0.24	1.42	0.47	1.10	0.87
olfactory region, adult	10195-103E6	121.32	0.57	4.20	0.00	2.87	0.38	4.78	1.15
optic nerve, donor1	10277-104E7	218.11	0.00	2.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	208.91	0.91	4.78	1.03	0.34	0.91	0.23	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	136.70	0.14	4.67	0.82	1.51	0.69	0.14	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	131.06	2.54	1.69	0.17	0.85	0.68	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	170.72	0.35	1.16	0.12	0.23	0.35	0.12	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	139.05	2.94	2.65	1.47	1.76	0.29	0.00	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	232.65	0.93	4.67	1.87	1.87	0.00	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	94.15	9.54	1.06	0.42	0.64	0.21	0.00	0.21
ovary, adult, pool1	10020-101D2	117.58	0.26	0.17	0.79	0.17	0.09	0.09	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	160.22	9.90	4.22	2.93	0.55	0.92	0.00	0.73
pancreas, adult, donor1	10049-101G4	276.55	4.70	0.94	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	139.49	1.40	1.12	0.00	0.56	0.84	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	119.76	2.04	1.36	1.19	0.00	0.51	0.00	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	91.90	1.82	0.33	0.50	0.00	0.00	0.00	0.33
paracentral gyrus, adult, pool1	10035-101E8	145.70	0.18	4.76	0.92	3.20	0.18	4.21	1.65
parietal cortex, adult, donor10258	10373-105G4	106.43	0.00	1.47	0.00	3.67	0.00	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	143.89	0.00	0.94	1.88	2.82	0.00	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	139.67	0.57	3.42	0.57	1.14	0.57	3.14	0.00
parietal lobe, adult, pool1	10034-101E7	141.87	0.18	4.14	0.97	2.29	0.44	4.23	1.15
parietal lobe, fetal, donor1	10072-101I9	78.56	2.91	0.00	1.94	1.94	0.97	0.00	3.88
parietal lobe, newborn, donor10223	10356-105E5	36.64	0.37	1.87	3.36	2.24	0.00	0.37	1.12
parotid gland, adult	10199-103F1	233.10	1.85	0.62	1.23	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	146.63	0.54	0.00	0.00	0.54	1.61	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	100.78	0.56	1.67	0.00	0.00	0.00	0.56	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	201.06	1.02	0.87	0.15	0.29	0.44	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	116.75	0.00	1.29	0.00	0.65	1.29	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	173.52	0.59	0.00	0.59	0.00	0.59	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	107.23	0.63	2.51	0.00	1.25	0.00	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	137.60	9.11	1.01	0.00	4.05	1.01	0.00	3.04
pituitary gland, adult, donor10252	10162-103A9	220.46	1.56	3.65	0.52	0.52	2.61	0.52	1.56
pituitary gland, adult, donor10258	10378-105G9	164.29	3.40	5.11	0.85	0.85	9.36	0.00	0.85
placenta, adult, pool1	10021-101D3	86.00	1.18	1.08	0.54	0.00	2.15	0.00	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	164.34	2.78	0.40	0.00	0.26	1.19	0.13	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	122.02	1.09	1.09	0.00	0.47	0.16	0.00	0.16
pons, adult, pool1	10033-101E6	109.91	0.52	3.44	0.95	0.60	0.95	0.86	0.26
postcentral gyrus, adult, pool1	10032-101E5	160.75	0.00	4.79	0.87	2.53	0.09	3.92	0.96
promyelocytes/myelocytes PMC, donor1	12132-128D8	340.90	8.37	6.27	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	203.80	0.00	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	352.07	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	141.29	6.70	3.20	1.31	1.17	0.44	0.29	0.73
prostate cancer cell line:PC-3	10439-106E7	261.73	3.81	4.72	4.54	1.09	0.73	0.73	1.09
prostate, adult, pool1	10022-101D4	130.60	0.09	0.54	0.09	0.00	0.36	0.18	0.09
putamen, adult, donor10196	10176-103C5	120.63	1.42	6.14	0.94	5.90	0.94	17.70	1.18
putamen, adult, donor10252	10152-102I8	129.41	1.96	5.88	0.00	5.88	0.00	11.76	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	81.96	0.00	1.09	2.19	2.19	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	105.58	0.24	4.59	0.97	2.42	0.24	2.90	1.45
putamen, newborn, donor10223	10365-105F5	22.49	0.75	0.75	0.75	1.50	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	99.21	2.62	1.45	0.58	0.00	1.75	0.00	0.29
rectum, fetal, donor1	10067-101I4	258.72	4.17	1.39	1.39	1.39	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	123.38	2.33	2.33	0.21	0.00	0.64	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	91.13	19.05	6.21	1.66	0.41	0.83	0.00	1.24
retina, adult, pool1	10030-101E3	164.01	0.40	1.69	0.40	0.30	0.60	0.00	0.30
retinoblastoma cell line:Y79	10475-106I7	161.86	14.29	4.94	0.78	0.78	3.12	0.00	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	99.59	12.91	4.67	2.46	1.23	0.12	0.25	0.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	402.96	6.75	5.34	0.84	2.81	0.56	0.28	2.53
sacrococcigeal teratoma cell line:HTST	10695-109G2	246.30	1.52	3.79	0.00	0.00	0.76	0.00	1.52
salivary acinar cells, donor1	11771-123I7	124.63	0.49	1.13	0.00	0.32	0.00	0.16	0.00
salivary acinar cells, donor2	11772-123I8	139.20	0.14	1.24	0.14	0.14	0.00	0.00	0.00
salivary acinar cells, donor3	11773-123I9	227.08	0.00	0.66	0.00	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	244.80	1.14	1.72	0.57	0.00	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	72.42	0.25	2.95	0.84	0.34	0.34	0.00	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	81.46	0.35	3.29	0.71	0.59	0.82	0.12	0.12
seminal vesicle, adult	10201-103F3	142.85	0.00	1.59	0.00	0.53	0.00	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	59.03	2.43	0.49	0.00	0.24	0.73	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	116.51	1.26	1.26	1.51	0.75	0.50	0.00	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	156.55	2.01	4.01	6.02	4.01	1.00	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	142.51	3.09	4.84	2.01	2.15	0.67	0.40	1.61
signet ring carcinoma cell line:Kato III	10436-106E4	161.59	0.77	0.88	0.11	0.33	1.55	0.11	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	147.86	0.65	2.84	0.13	0.39	0.65	0.00	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	267.42	0.00	0.00	0.00	0.00	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	161.92	0.00	0.00	0.00	0.12	0.00	0.12	0.00
skeletal muscle, fetal, donor1	10066-101I3	243.21	1.01	2.01	0.00	0.00	3.02	0.00	0.00
skin, adult, donor1	10074-102A2	142.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	176.74	0.63	1.26	0.63	0.00	1.26	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	301.84	4.34	2.33	1.00	0.67	1.33	1.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	91.41	2.84	0.63	0.00	0.32	0.63	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	126.44	2.51	1.93	0.19	0.77	0.19	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	290.76	1.32	1.15	0.16	0.16	0.16	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	204.28	8.20	0.97	0.00	0.16	0.32	0.32	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	141.65	6.10	0.22	0.00	0.00	0.87	0.00	0.22
small intestine, adult, pool1	10024-101D6	178.69	0.84	4.54	0.12	0.36	0.84	0.12	0.24
small intestine, fetal, donor1	10064-101I1	219.41	2.46	12.28	0.98	0.98	9.34	0.00	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	103.09	1.03	0.51	0.00	0.00	0.51	0.00	1.54
smooth muscle, adult, pool1	10048-101G3	181.95	0.00	0.26	0.26	0.26	0.00	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	191.37	2.41	1.07	0.27	0.00	0.27	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	152.55	0.00	1.38	0.69	0.69	1.15	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	94.62	0.39	0.00	0.39	0.00	0.39	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	93.39	0.00	2.08	0.69	0.00	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	113.43	1.22	0.61	0.61	0.61	1.22	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	63.37	0.00	0.00	0.00	0.00	0.46	1.84	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	166.23	2.24	2.99	2.39	1.05	0.75	0.15	1.34
spleen, adult, pool1	10025-101D7	116.08	0.66	0.22	0.00	0.11	0.11	0.22	0.00
spleen, fetal, pool1	10044-101F8	111.00	1.43	1.11	0.24	0.56	0.48	0.08	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	145.43	0.72	0.31	0.10	0.00	0.31	0.21	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	150.19	0.38	2.66	0.00	0.00	0.57	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	123.36	5.24	1.75	0.00	0.70	0.70	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	160.28	5.08	1.56	1.95	0.39	1.56	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	183.36	0.79	0.90	0.34	0.34	1.58	0.11	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	58.03	0.42	1.27	0.00	0.00	0.42	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	125.65	0.42	0.85	0.85	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	480.59	4.27	4.27	0.00	0.00	2.14	0.00	1.07
submaxillary gland, adult	10202-103F4	152.10	0.00	1.14	0.00	0.00	0.00	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	119.85	0.21	1.25	0.42	0.21	0.21	0.42	0.42
substantia nigra, adult, donor10258	10371-105G2	141.21	0.00	5.69	0.52	1.55	1.55	0.52	2.59
substantia nigra, newborn, donor10223	10358-105E7	57.23	0.00	0.71	1.41	1.41	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	223.53	16.74	4.13	0.46	1.38	1.15	0.46	2.52
temporal lobe, adult, pool1	10031-101E4	159.45	0.51	5.59	0.68	4.32	0.59	13.73	1.10
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	122.51	2.14	2.14	0.71	1.42	0.71	0.00	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	71.21	1.32	0.44	0.88	0.44	0.44	0.00	0.88
tenocyte, donor1	11763-123H8	77.85	1.75	7.33	3.84	1.05	0.00	0.00	1.75
tenocyte, donor2	11765-123I1	103.39	0.76	3.82	1.53	0.00	0.38	1.14	0.00
tenocyte, donor3	11768-123I4	110.09	0.74	6.30	1.48	0.74	0.37	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	152.28	7.14	2.55	1.19	0.85	0.85	0.51	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	172.80	7.71	2.16	0.92	1.39	1.54	0.15	1.70
teratocarcinoma cell line:PA-1	10807-111A6	134.21	8.99	1.08	0.46	0.46	0.15	0.00	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	60.93	4.57	0.63	0.76	0.89	0.13	0.13	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	105.13	3.03	1.13	0.76	0.38	0.38	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	41.23	2.51	0.44	0.22	0.11	0.00	0.00	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	124.42	7.49	0.33	1.95	0.65	0.00	0.65	0.33
testis, adult, pool1	10026-101D8	119.29	0.21	2.58	0.54	0.21	0.86	0.00	0.00
testis, adult, pool2	10096-102C6	177.28	2.26	5.41	0.90	1.80	2.71	0.45	0.45
thalamus - adult, donor10196	10168-103B6	153.45	1.10	9.94	0.00	0.00	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	119.87	0.16	0.63	0.16	1.09	0.00	2.50	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	104.69	0.00	6.16	0.00	1.54	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	66.21	0.00	2.31	0.00	0.66	0.99	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	22.44	0.58	2.30	1.73	5.18	0.00	0.00	1.73
throat, adult	10209-103G2	131.58	0.25	1.00	0.25	0.00	0.00	0.00	0.00
throat, fetal, donor1	10061-101H7	168.81	2.13	0.61	0.00	0.30	1.52	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	136.13	5.37	2.98	0.20	0.79	0.79	0.20	0.79
thymus, adult, pool1	10027-101D9	119.00	2.39	1.29	1.09	0.70	0.80	0.00	0.60
thymus, fetal, pool1	10043-101F7	108.27	2.91	0.83	1.04	0.31	1.04	0.31	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	99.59	2.39	1.60	1.60	0.53	1.73	0.13	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	182.30	3.77	1.12	0.70	0.28	1.12	0.28	0.28
thyroid, adult, pool1	10028-101E1	145.85	0.09	0.56	0.09	0.00	0.00	0.28	0.00
thyroid, fetal, donor1	10060-101H6	186.41	1.05	0.53	0.79	0.53	0.53	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	221.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	123.50	0.23	1.63	0.00	0.00	0.47	0.23	0.23
tongue, fetal, donor1	10059-101H5	239.61	0.00	0.39	0.00	0.39	1.97	0.39	0.00
tonsil, adult, pool1	10047-101G2	158.58	0.60	1.00	0.10	0.00	0.40	0.00	0.10
trachea, adult, pool1	10029-101E2	118.12	0.74	0.65	0.08	0.00	0.00	0.08	0.00
trachea, fetal, donor1	10058-101H4	176.19	2.69	0.00	0.00	0.00	0.77	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	147.02	0.71	4.61	1.77	1.06	0.35	0.35	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	126.75	3.34	1.32	1.93	0.30	1.52	0.00	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	140.23	3.45	2.82	0.78	0.00	0.63	0.63	0.16
tridermal teratoma cell line:HGRT	10694-109G1	332.94	0.00	5.71	0.00	3.81	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	171.08	1.10	2.29	0.42	0.59	0.42	0.25	0.76
umbilical cord, fetal, donor1	10057-101H3	141.88	4.17	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	132.58	0.17	0.68	0.00	0.17	0.51	0.00	0.00
uterus, fetal, donor1	10055-101H1	168.42	3.58	0.51	0.51	1.02	0.51	0.00	0.00
vagina, adult	10204-103F6	115.02	0.00	0.00	0.00	0.00	0.65	0.65	0.00
vein, adult	10191-103E2	124.94	0.66	0.66	0.44	0.22	0.22	0.44	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	126.84	2.40	1.34	0.00	0.27	0.80	0.00	0.00

Property "Nearest transcripts" (as page type) with input value "ENST00000439686.6:9 AF267748:-88 NM_001278380.2:99 ENST00000454885.6:-177 EU624491:-177 ENST00000392433.3:189 AK027285:189 BC094839:-346 ENST00000456762.3:398 KJ902582:400 KJ902583:400 ENST00000357866.4:401 DQ099385:401 ENST00000426960.6:-409 EF036485:416 NM_001400284.1:-439 NM_001278379.2:-439 NM_001400283.1:-439 NM_001400285.1:-439 NM_001400320.1:-439 NM_001400281.1:-439 NM_001400282.1:-439 ENST00000413381.6:-441 ENST00000542099.5:-481 ENST00000392435.7:-481 ENST00000453766.7:-483 ENST00000539770.6:-493" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.